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ABSTRACT 
 
 
 
The Regulation of Growth Factor Signaling in Drosophila  
 
Development and Disease. 
 
(December 2010) 
 
Jonathan Ryan Lindner, B.S., University of Wisconsin 
 
Chair of Advisory Committee: Dr. Sumana Datta 
 
 
  
Developmental signaling pathways have many diverse roles throughout the life 
of an organism.  The proper regulation of these pathways is essential for normal 
development, and misregulation can lead to diseases such as cancer.  Heparan sulfate 
proteoglycans function to modulate growth factor signaling in many biological processes 
by acting as co-receptors, or by influencing ligand distribution.  The heparan sulfate 
proteoglycan Trol, the Drosophila Perlecan homolog, is known to modulate signaling in 
a population of neuroblasts in the developing Drosophila central nervous system.  My 
studies aim to determine the function Trol has in regulating signaling pathways during 
development.  trol mutants are examined to determine how various mutant alleles impact 
signaling in several different developmental contexts.  The role growth factor pathways 
play during induction of a Drosophila prostate cancer model is also examined.  Gene 
expression profiles are determined for two types of prostate model overproliferation.  
Trol is shown to be able to differentially regulate multiple signaling pathways during 
several developmental processes.  The Drosophila prostate cancer model is also shown 
iv 
 
to have many characteristics similar to those of human prostate cancer, and that 
signaling and proteoglycan expression are impacted by aberrant overgrowth in the 
model.  My results indicate that Trol is able to specifically modulate different signaling 
pathways depending on the tissue and developmental context.   
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CHAPTER I 
INTRODUCTION 
 
 Signaling by growth factors has diverse and essential roles in countless biological 
processes.  Many of the processes affected are conserved across organisms, making the 
study of their regulation central to a full understanding of how these signaling cues are 
used in such a wide range of events.   During development, growth factors help to 
regulate the assembly and growth of tissues and organs.  Signaling molecules and their 
downstream pathways play a role in controlling gene expression and function, allowing 
for the proper assembly and patterning of structures.  The same signaling pathways that 
are critical for development are also important for an organism after maturation.   
Maintenance of tissues and organs, as well as immunological responses and other 
biological processes, are coordinated by growth factor signaling.  Inadequate regulation 
of these pathways can lead to problems such as disease or degeneration of an organism’s 
tissues and organs.  In fact, misregulation of growth factor signaling has been shown to 
impact the metastatic potential of different cancers. 
The strict regulation of signaling pathways is essential at all times during the life 
of an organism.  Many growth factor signaling pathways are dependent upon the 
extracellular matrix.  Heparan sulfate proteoglycans (HSPGs) are an integral component  
 
 
 
 
____________ 
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of the extracellular matrix, and many signaling molecules rely on HSPGs for the proper 
modulation of signaling.  Examining how growth factor signaling impacts such a wide 
range of both positive and negative biological processes will help to better understand 
ways in which developmental signaling pathways and their regulators can be utilized in 
treating problems from early development to disease.  The conserved, universal nature of 
these pathways allows for their study in lower organism model systems, such as 
Drosophila melanogaster. 
 
Drosophila Model System 
 The Drosophila system has been used extensively as a model for signal 
transduction during development.  Many components of the signaling pathways that are 
present in higher organisms exist in Drosophila as well.  However, the small genome 
size of Drosophila decreases the complexity found in mammalian systems.  Due to the 
long history of research in this model system, a sophisticated set of molecular and 
genetic tools, as well as numerous mutant lines, have been developed.  Furthermore, 
Drosophila has a relatively short life span consisting of distinct morphological stages, 
making this model system ideal for study of developmental processes.  After an egg is 
fertilized, embryogenesis lasts one day, after which the egg hatches and the first of three 
larval stages begins.  The first instar larval stage lasts one day, followed by a second 
instar stage for another twenty-four hours, and finally a third instar stage, which lasts 
two days.  The Drosophila pupal stage lasts approximately five days, after which an 
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adult fly emerges.  The vast knowledge base of Drosophila biology, and specifically 
growth factor signaling pathway components, transduction, and regulation, make it a 
valuable model system for the study of signaling in different biological processes. 
 
Drosophila model for development 
 Drosophila has been widely used as a model for various developmental 
processes.  The presence of a similar set of developmental pathways and molecules to 
that of other organisms allows for extrapolation of the information gained to other 
systems.  The relatively small genome size of Drosophila decreases genetic redundancy 
in the fly compared to vertebrates.  For example, where mammals have three Hedgehog 
growth factor ligands, Sonic Hedgehog, Indian Hedgehog, and Desert Hedgehog, 
Drosophila contains only one (Ingham and McMahon, 2001; Carpenter et al., 1998).  
Similarly, mammals contain twenty-two Fibroblast Growth Factor molecules with four 
different receptors, while Drosophila has three Fibroblast Growth Factor molecules and 
two receptors (Tsang and Dawid, 2004; Gryzik and Muller, 2004; Stathopoulos et al., 
2004).  The study of these pathways in Drosophila has led to the discovery of many 
roles these growth factors play during development.  For example, Drosophila 
Hedgehog (Hh) is important for anterior-posterior patterning, segmental polarity, and 
central nervous system development (Lum and Beachy, 2004; Tabata and Takei, 2004; 
Tabata and Kornberg, 1994; Park et al., 2003).  Cell migration and tracheal development 
utilize Fibroblast Growth Factor (Branchless, or Bnl) in the fly (Venkataraman et al., 
1999; Powers et al., 2000; Bottcher and Niehrs, 2005; Sutherland et al., 1996).  The 
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Drosophila gene for Wnt, wingless (Wg), is responsible for synapse development in 
larval stages, as well as patterning as a segment polarity gene (Logan and Nusse, 2004; 
Wodarz and Nusse, 1998; Bhat, 1996).  The Transforming Growth Factor- like 
molecule Decapentaplegic (Dpp) has roles in limb patterning and dorsal/ventral polarity 
during embryogenesis (Tabata et al., 1995; Affolter and Basler, 2007).   
All of these signaling molecules have been examined in various developmental 
systems.  In many cases, more than a single pathway is utilized during a developmental 
event.  For example, both Hh and Bnl are important during the reactivation of a 
particular subset of quiescent neural stem cells in the developing larval brain (Barrett et 
al., 2008).  Understanding the regulation of signaling pathways when multiple pathways 
are functioning, as well as at any point during a developmental process, is of vital 
importance. 
 
Drosophila central nervous system development 
 The Drosophila central nervous system utilizes a number of signaling pathways 
throughout development.  Neurogenesis in flies occurs in two distinct phases, an 
embryonic stage and postembryonic stage.  During embryogenesis, the central brain, 
thoracic, and abdominal neuroblasts are formed when the cells of the ventral and 
procephalic neuroectoderm are divided into neural equivalence groups (Figure 1.1A).  
Expression of the segment polarity genes wingless, hedgehog, and engrailed, along with 
muscle segment homeobox, ventral nervous system defective, and intermediate 
neuroblast defective, lead to the establishment of the groups containing five to seven  
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Figure 1.1.  Neuroblast specification in the Drosophila central nervous system.  (A) 
Neuroblasts arise from neural equivalence groups of five to seven cells established by 
expression of proneural genes.  The presumptive neuroblast delaminates basally, 
followed by asymmetric division.  (B) The cell in the equivalence group with the highest 
expression of achaete-scute becomes the presumptive neuroblast.  It expresses Delta, 
which activates Notch signaling in the adjacent cells, which leads to downregulation of 
proneural gene expression and an epidermal fate. 
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neuroectoderm cells (Doe, 1992; Doe, 1996; Urbach et al.,2003; Egger et al., 2007).  In 
the neural equivalence group, all of the cells express the achaete-scute complex.  The 
cell that has the highest level of achaete-scute expression will be designated to become a 
neuroblast through lateral inhibition (Egger et al., 2007).  Lateral inhibition occurs when 
the cell fated to become the neural stem cell expresses the transmembrane signaling 
ligand Delta (Figure 1.1B).  This in turn activates the receptor for Delta, Notch, in all of 
the other cells in the neural equivalence group (Artavanis-Tsakonas and Simpson, 1991).  
After the Notch pathway is activated in the adjacent cells, proneural gene expression is 
downregulated.  The decrease in proneural gene expression leads these adjacent cells to 
adopt an epidermal fate.  This allows the original, Delta-expressing cell to be the sole 
neuroblast that forms from that neural equivalence group.  The cell fated to become a 
neuroblast then becomes larger and delaminates.  The new neuroblast begins to divide 
asymmetrically, giving rise to two daughter cells.  This asymmetric division results in a 
new neuroblast and a ganglion mother cell.  The ganglion mother cell then divides 
symmetrically to give rise to two progenitor cells (Figure 1.2).  These progenitor cells 
will differentiate into glial cells or neurons (Hartenstein et al., 1987; Prokop and 
Technau, 1991; Doe, 1996).   
 Optic lobe neural stem cells also begin formation during embryogenesis.  These 
neuroblasts are formed from an optic placode dorsolateral to the embryonic brain.  After 
embryonic stage eleven, the optic placode invaginates and fuses to the brain (Green et 
al., 1993; Hartenstein, 1993; Ebens et al., 1993).  After fusion, the optic lobe cells divide 
symmetrically, in contrast to the other embryonic neuroblasts that divide  
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Figure 1.2. Asymmetric neural stem cell division in Drosophila.  Neuroblasts can 
divide asymmetrically to give rise to two daughter cells: another neuroblast and a 
ganglion mother cell.  The ganglion mother cell then divides symmetrically to produce 
two progenitor cells (neurons or glial cells). 
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asymmetrically.  These neuroepithelial optic lobe progenitor cells generate neuroblasts 
that will divide asymmetrically during the second instar larval stage (Egger et al., 2007).  
The optic lobe neuroblasts separate into the inner proliferative center and the outer 
proliferative center, which will eventually give rise to adult optic structures (Hofbauer 
and Campos-Ortega, 1990; Ebens et al., 1993).  At the end of embryogenesis, all of the 
neural stem cell groups stop dividing and become quiescent, with the exception of the 
mushroom body and ventral lateral populations (Truman and Bate, 1988; White and 
Kankel, 1978; Prokop and Technau, 1991).  
 After embryogenesis, the post-embryonic stage of Drosophila CNS development 
occurs in multiple stages.  Most of the cells for the adult central nervous system are 
generated during this post-embryonic developmental period (Truman and Bate, 1988; 
Maurange and Gould, 2005).  Reactivation of quiescent neuroblasts occurs in a strict 
spatial and temporal pattern (Figure 1.3).  The neuroblasts of the central brain and optic 
lobe resume division during the late first instar stage (Ito and Hotta, 1991).  Two to six 
hours after the start of the second instar phase, the thoracic neuroblast population exits 
quiescence and resumes asymmetric division (Truman and Bate, 1988; Datta, 1995).   
 
Neural stem cell regulation 
The regulation of neural stem cells in the Drosophila larval central nervous 
system is a complex process.  Multiple different populations of quiescent neuroblasts 
respond to various signals that direct the stem cells to resume proliferation in a very  
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Figure 1.3.  Reactivation of quiescent neural stem cells in the Drosophila central 
nervous system.  Neuroblasts (NBs) in the Drosophila larval brain resume proliferation 
in a distinct spatial and temporal pattern.  The mushroom body (MB) and ventral lateral 
(VL) neuroblasts continue to proliferate throughout embryogenesis and larval 
development.  After entering quiescence at the end of embryogenesis, the optic lobe 
(OL) and central brain (CB) neuroblasts resume proliferation during mid-1
st
 instar.  The 
thoracic neuroblasts exit quiescence during early 2
nd
 instar. 
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distinct pattern.  Several genes have been identified that influence the reactivation of 
these cell populations during the post-embryonic phase of neural development.   
 terribly reduced optic lobes, or trol, was first identified in a screen for mutations 
that affected Drosophila larval brain morphology (Datta and Kankel, 1992).  trol 
encodes the Drosophila Perlecan, a heparan sulfate proteoglycan (Park et al., 2003; 
Voigt et al., 2002).  Loss-of-function mutations in trol have been shown to disrupt the 
ability of neural stem cells to exit quiescence and resume proliferation (Datta, 1995).  
Overexpression of cyclin E, which is required for the G1-S transition, is able to rescue 
the trol loss-of-function mutation, which suggests that quiescent neuroblasts are G1 
arrested.  Ectopic expression of Drosophila cdc25, or string, is also able to rescue 
proliferation in the trol mutant phenotype (Caldwell and Datta, 1998; Park et al., 2003).  
Taken together, this data strongly suggests that quiescent neuroblasts are arrested in the 
G1 phase of the cell cycle. 
anachronism encodes a glycoprotein that is secreted by glial cells in the 
Drosophila larval CNS.  Loss-of-function mutants for this gene increase the number of 
proliferating stem cells, which suggests that anachronism is important in the 
maintenance of neuroblast quiescence (Ebens et al., 1993).  The epistatic relationship 
between these two genes can be determined using a double loss-of-function mutant.  The 
double mutant shows that anachronism is epistatic to trol, which suggests that trol 
functions to inhibit the repressive effect of anachronism on cell cycle progression (Datta, 
1995). 
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 hedgehog and branchless (Drosophila Sonic hedgehog and FGF-2, respectively) 
are both crucial during Drosophila CNS development.  Expression of these genes is able 
to partially rescue a trol mutant phenotype in the optic lobe and central brain populations 
of neuroblasts during the first instar larval stage (Park et al., 2003).  These growth factor 
ligands have been shown to act together in a positive feedback loop to help regulate the 
onset of neuroblast division in a particular subset of cells in the Drosophila central 
nervous system (Barrett et al., 2008).  Furthermore, co-immunoprecipitation analysis 
identified physical interactions between both the Branchless ligand and Trol, and the 
Hedgehog ligand and Trol (Park et al., 2003).  This implicates these growth factors, with 
their function modulated by the heparan sulfate proteoglycan Trol, as necessary 
components of the neuroblast regulatory machinery during first instar CNS development.  
What is less clear is whether Hedgehog and Branchless operate in a similar fashion in 
other spatially and temporally distinct populations of neuroblasts, or whether other 
growth factor signaling pathways known to be modulated by Trol also play a role in the 
reactivation of quiescent neuroblasts. 
The distinct spatial and temporal patterns in which quiescent neuroblasts resume 
division in the developing Drosophila central nervous system can be used to address a 
number of questions.  Do the spatially and temporally distinct populations of neuroblasts 
respond to the same signaling cues when resuming proliferation?  How are these 
signaling cues regulated differently for the different stages of central nervous system 
development?  And is this regulation similar to the regulation of signaling pathways in 
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other areas of Drosophila development?  These questions will be addressed in Chapter II 
of this dissertation 
 
Plasmatocyte and larval disc development 
 Another system in which to study growth factor signaling during Drosophila 
development is hemocyte production.  Prohemocytes are formed in the lymph gland of 
third instar larvae (Evans et al., 2003).  After maturation, hemocytes are released into the 
hemolymph, and circulate as three different cell types.  Cell cycle marker staining 
reveals that these circulating hemocytes continue to proliferate at a slow rate (Qiu et al., 
1998; Asha et al., 2003).  The hemocytes continue to respond to growth factor signaling 
cues, as activation of the Ras-MAPK pathway through expression of a constitutively 
active form of Ras leads to a 40-fold increase in cell numbers (Asha et al, 2003).   
Vascular Endothelial Growth Factor (VEGF) and Platelet Derived Growth Factor 
(PDGF) are two signaling pathways that work through the Ras-MAPK pathway, and 
decreasing the expression of their receptor in plasmatocytes leads to increased hemocyte 
cell death (Evans et al., 2003).  Furthermore, Perlecan has been shown to modulate 
signaling by mammalian homologs of both growth factors (Iozzo, 2005).   Therefore, 
hemocyte production and maintenance in Drosophila is another intriguing system in 
which to study growth factor signaling and its regulation during development.  
 Drosophila larval disc development has been a very successful system in the 
study of growth factor signaling.   Many of the developmental signaling pathways have 
been widely studied in this system, and numerous insights have been gained on how 
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these pathways function and interact during development.  Drosophila imaginal discs are 
specified by the fifth hour of embryogenesis and can be recognized later as small sacs of 
epithelial cells that have invaginated from the epidermis (Cohen et al., 1993; Couso et 
al., 1993; Li et al., 1995).  Imaginal disc cells continue to proliferate during larval 
development to form a folded epithelial sheet that eventually differentiates into various 
adult structures (Li et al., 1995).  The expression of the growth factor wingless, which is 
found only in the ventral region of early leg and wing discs, is required for cells to adopt 
ventral fates (Baker, 1988; Couso et al., 1993; Williams et al., 1993; Li et al., 1995).  In 
the posterior region of thoracic discs, the signaling molecule gene hedgehog is 
transcribed, and influences the development and patterning of both the anterior and 
posterior compartments by inducing other growth factor molecules at the anteroposterior 
boundary (Mohler, 1988; Basler and Struhl, 1994; Li et al., 1995; Lee et al., 1992; 
Tabata et al., 1992).  In the developing Drosophila eye disc, several other signaling 
pathways have also been shown to be active (Kaphingst and Kunis, 1994; Silver and 
Rebay, 2005).  These examples demonstrate the importance of Drosophila larval disc 
development to the understanding of growth factor signaling during developmental 
processes. 
In this section, I have described some of the benefits the Drosophila model 
system gives researchers studying development.  I have reviewed Drosophila central 
nervous system development and regulation, as well as several other developmental 
processes that are useful in the study of growth factor signaling and the modulation of 
these important pathways.  I am interested in gaining a better understanding of how these 
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same signaling pathways result in such diverse responses during different biological 
processes, and specifically if the regulation of these pathways plays a role in the 
different responses.  To fully understand these complex regulatory processes, it is 
important to have an excellent grounding in the mechanisms and components of the 
signaling pathways themselves. 
 
Signaling Pathways in Development 
 Growth factor signaling pathways have countless diverse and essential roles 
throughout the lifetime of an organism.  Signaling induced by the Hedgehog, Fibroblast 
Growth Factor, Wnt, and Bone Morphogenetic Protein groups of ligands affect processes 
during development as well as later in adult life.  These pathways are highly conserved 
across all species, and knowledge gained from their study in invertebrates can and has 
been applied to humans (Echelard et al., 1993; Kumar et al., 1996).  Signaling by these 
growth factors has been extensively studied, and much is known about the ligands and 
other pathway components.  However, discovery of new pathway functions, interactions, 
and components demonstrate the need for further research into how these complex 
processes work. 
  
Hedgehog pathway 
 The hedgehog (hh) gene was first discovered in Drosophila during a genetic 
screen for defects in segmental patterning (Nusslein-Volhard and Wiesehaus, 1980).  
The ligand acts as a morphogen, and is capable of both short and long range signaling 
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(Roelink et al., 1995).  Among many other developmental processes, signaling from the 
Hedgehog pathway influences anterior-posterior patterning, segmental polarity, neural 
tube development, limb patterning, and reactivation of quiescent neuroblasts (Lum and 
Beachy, 2004; Park et al., 2003).  However, the effects of Hedgehog signaling reach 
further than early development.  Hh signaling has been shown to be involved in tissue 
homeostasis, and misregulation of the Hedgehog pathway has been implicated in various 
diseases, including breast cancer, small-cell lung cancer, pancreatic cancer, basal cell 
carcinomas, and prostate cancer (Watkins et al., 2003; Thayer et al., 2003, Shaw and 
Bushman, 2007; Roessler et al., 2003; Kubo et al., 2004; Lau et al., 2006).  With such 
wide ranging and potentially deadly roles during development and disease, 
understanding how this pathway operates, including how it is regulated, is critical. 
 The Hedgehog pathway is highly conserved in vertebrates; although gene 
families of the ligand, receptor, and transcription factor exist that have partial 
redundancy.  In Drosophila, the Hedgehog ligand is an approximately 19 kDa molecule 
that is produced from the autoproteolytic cleavage of a 46 kDa precursor protein (Lee et 
al., 1994; Porter et al., 1995).  During the autoproteolytic cleavage event, a cholesterol 
moiety required for proper secretion of the protein is added, after which the 19 kDa 
ligand is further modified by the addition of a palmitate fatty acid group in the Golgi 
complex (Porter et al., 1996; Ingham and McMahon, 2001; Ho and Scott, 2002; 
Micchelli et al., 2002; Miura and Treisman, 2006).  Hedgehog is then recognized by its 
cholesterol moiety and secreted from the cell by Dispatched, a transmembrane protein 
(Burke et al., 1999).  Hedgehog acts as a morphogen, and participates in both short and 
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long range signaling.  The posttranslational modifications help to determine the signal 
range through multimerization, membrane tethering, and interactions with extracellular 
proteins (Zeng et al., 2001; Gallet et al., 2003; Lum and Beachy, 2004).    
The Hedgehog signal is received by its receptor Patched, a 12-pass 
transmembrane protein with a sterol sensing domain (Taipale et al., 2002).  When the 
ligand is not present, Patched inhibits the 7-pass transmembrane protein Smoothened 
(Figure 1.4).  This inhibition promotes the formation of complex-1, consisting of the 
kinases Fused, Protein Kinase A, Glycogen Synthase Kinase-3, Casein Kinase-1, the 
scaffolding protein Costal 2, and the transcription factor Cubitus Interruptus (Hooper 
and Scott, 2005).  When in complex 1, Cubitus Interruptus is phosphorylated and 
cleaved into an N-terminal fragment, which translocates into the nucleus and acts as a 
target gene repressor (Osterlund and Kogerman, 2006, Hooper and Scott, 2005).  
Suppressor of Fused sequesters the remaining unprocessed Cubitus Interruptus in the 
cytoplasm (Lum and Beachy, 2004).  In the presence of the Hh ligand, Hedgehog binds 
to the receptor Patched, which then releases its inhibitory influence on Smoothened.  The 
resulting phosphorylation of Smoothened leads to the dissociation of complex 1, which 
allows unprocessed Cubitus Interruptus to enter the nucleus and act as a transcriptional 
activator of Hedgehog target genes such as patched (Osterlund and Kogerman, 2006).  
Other components also may play a role in signaling by the growth factor Hedgehog.  The 
transmembrane protein interference Hedgehog (Ihog), a homolog of mammalian CDO, 
has been shown to interact with the Hedgehog ligand and help modulate its signal (Yao 
et al., 2006).  Genetic interaction studies have shown the extracellular matrix protein 
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Figure 1.4.  The Hedgehog signaling pathway.  In the absence of the Hedgehog (Hh) 
ligand, the receptor Patched (Ptc) inhibits the transmembrane protein Smoothened 
(Smo), allowing for the formation of Complex I.  Complex I can then bind the 
transcription factor Cubitus Interruptus (Ci), which then is phosphorylated and cleaved 
into a transcriptional repressor (CiR). When Hh is present, it binds to its receptor, 
releasing the inhibitory effect of Ptc on Smo.  Smo is then phosphorylated and can 
interact with Fused (Fu), preventing formation of Complex I and allowing Ci to act as a 
transcriptional activator (CiA). 
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Trol (the Drosophila Perlecan) to be required for full strength Hedgehog signaling (Park 
et al., 2003).   
   
Branchless pathway 
 Basic Fibroblast Growth Factor (FGF-2) was identified in 1973 as a mitogen that 
could stimulate mouse fibroblast growth (Armelin, 1973; Gospodarowicz, 1974).  It 
quickly became apparent that many different polypeptide growth factors fit into the FGF 
family, and the role of these growth factors far exceeded inducing fibroblast growth.  
During development, FGFs influence tracheal development, cell migration, mesoderm 
induction, and reactivation of mitotically arrested neuroblasts, among many other 
processes (Sutherland et al., 1996; Venkataraman et al., 1996; Park et al., 2003).  FGFs 
also function after development by impacting homeostasis, angiogenesis, and tumor 
formation (Venkataraman et al., 1999; Powers et al., 2000; Bottcher and Niehrs, 2005).   
The Fibroblast Growth Factor pathway is highly conserved, and many of its 
components have been identified in a wide range of organisms.  Since the first FGF was 
identified, twenty-two FGFs have been found in vertebrates, while three have been 
found in Drosophila.  While all of the mammalian FGFs are smaller than 35 kDa, the 
FGFs in Drosophila are significantly larger at approximately 80 kDa (Ornitz, 2000; 
Ornitz and Itoh, 2001; Groth and Lardelli, 2002; Stathopoulos et al., 2004 Gryzik and 
Muller, 2004).  FGF proteins contain four domains including a signal peptide, an amino 
terminus, a conserved core region of 120 amino acids, and a carboxy terminus, of which 
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the core region is responsible for binding to receptors (Kan et al., 1993; Venkataraman et 
al., 1999; Thisse and Thisse, 2005, Ornitz, 2000).   
The Drosophila Basic Fibroblast Growth Factor (FGF-2) is represented by 
Branchless.  Branchless binds to one of two receptors in the fruit fly, Breathless or 
Heartless (Klambt et al., 1992).  FGF receptors have three general domains; an 
extracellular ligand binding domain itself consisting of three Ig domains and a heparan 
binding domain, a transmembrane domain, and a cytoplasmic tyrosine kinase domain 
(Klambt et al, 1992; Bottcher and Niehrs, 2005).  Activation of the receptor by an FGF 
ligand can induce signaling through multiple different pathways including the 
phospholipase C gamma pathway, the phosphatidylinositol-3 kinase pathway, and the 
pathway I will focus on, the Ras-Mitogen Activated Protein Kinase (Ras-MAPK) 
pathway (Sutherland et al., 2006; Powers et al., 2000; Tsang and Dawid, 2004; Bottcher 
and Niehrs, 2005).  When activated by Branchless, the receptors undergo dimerization, 
which leads to the activation of their intracellular kinase domains by trans-
phosphorylation of specific tyrosine sites (Powers et al, 2000).  The activation of the 
receptors results in the phosphorylation of FGF receptor substrate-2, which in turn 
recruits the adapter molecule Growth factor receptor bound protein-2 (Figure 1.5).  A 
complex is then formed with Son of sevenless, which can initiate the RAS-RAF-MEK-
MAPK kinase cascade through GTP exchange with Ras (Tsang and Dawid, 2004; Groth 
and Lardelli, 2002; Powers et al., 2000).  Various transcription factors are then 
phosphorylated and activated, allowing for transcription of target genes such as pointed 
and sprouty.  Working through a negative feedback loop, sprouty is also an inhibitor of  
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Figure 1.5.  The Branchless signaling pathway.  The Fibroblast Growth Factor 
signaling pathway is activated when the ligand Branchless (Bnl) binds and causes 
dimerization of its receptors (FGFR, Btl or Htl in Drosophila).  Trans-phosphorylation 
of the receptors leads to phosphorylation of FGF receptor substrate-2 (FRS2), which in 
turn recruits the adapter molecule Growth factor receptor bound protein-2 (GRB2).  
GRB2 then interacts with Son of sevenless, leading to the RAS-RAF-MEK-MAPK 
kinase cascade.  This results in the activation of various transcription factors (TFs), 
which leads to target gene transcription. 
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Branchless signaling (Huang and Stern, 2005, Guy et al, 2003).  FGF signaling also 
relies on extracellular matrix proteins such as heparan sulfate proteoglycans, which 
interact with both ligands and receptors and are required for receptor activation (Yayon 
et al., 1991; Rapraeger et al., 1991; Lin et al., 1999; Kan et al., 1993; Ornitz, 2000; Volk 
et al., 1999). 
 
Wingless pathway 
 wingless was first identified as a mutation that affected wing and haltere 
development in Drosophila (Sharma and Chopra, 1976).  Belonging to the Wnt family of 
secreted signaling molecules, the segment polarity gene wingless and its signaling 
pathway is highly conserved among organisms.  In flies, Wingless is required for many 
processes during embryogenesis, including the proper patterning of the epidermis, limb 
specification and patterning, and neural tube patterning (Bejsovec and Martinez Arias, 
1991; Bejsovec and Wieschaus. 1995; Nusslein-Volhard and Wieschaus, 1980; Wodarz 
and Nusse, 1998; Bhat, 1996; Patel et al., 1989; Fanto and McNeill, 2004).  Wnt 
signaling is also important beyond development, and misregulation of the signaling 
pathway has been seen in several human degenerative diseases and cancers (Spink et al., 
2000; Logan and Nusse, 2004). 
 Many of the canonical Wingless/Wnt pathway components were identified by 
mutations leading to altered cuticle patterning (Noordermeer et al., 1994; Siegfried et al., 
1994; Cadigan and Nusse 1997).  In the absence of the Wingless ligand, the 7-pass 
transmembrane G-protein coupled receptors of the Frizzled family are able to inactivate 
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Dishevelled, a phosphoprotein that helps propagate the signal (Penton et al., 2002; Wang 
and Malbon, 2004; Wallingford and Habas, 2005).  This allows for the formation of the 
destruction complex, which consists of the scaffold protein axin, the tumor suppressor 
gene product APC, Glycogen synthase kinase 3 (GSK-3), and the signal transducing 
protein β-catenin, also known as Armadillo in Drosophila (Figure 1.6).  When associated 
with the destruction complex, β-catenin is phosphorylated by casein kinase I , which in 
turn allows GSK-3 to phosphorylate β-catenin on three different serine/threonine 
residues.  This leads to β-catenin being targeted for ubiquitylation and proteolytic 
degradation.  When the Wnt ligand interacts with Frizzled, the receptor is able to bind 
the transmembrane protein LRP, a low-density
 
lipoprotein receptor-related protein 
essential for propagation of canonical Wnt signaling.  The destruction complex is then 
inhibited, and β-catenin is no longer degraded.  It is then able to translocate to the 
nucleus where it displaces the transcriptional repressor Groucho from the Tcf/Lef 
effector complex and induces expression of target genes such as sloppy paired in 
Drosophila (Wehrli et al., 2000; Katanaev et al., 2005; Liu et al., 2005a; Liu et al., 
2005b; Wallingford and Habas, 2005). 
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Figure 1.6. The Wingless signaling pathway.  In the absence of the ligand Wingless 
(Wg, Drosophila homolog of Wnt), the receptor Frizzled (Fz) is able to inhibit 
Disheveled (Dsh), leading to the formation of the destruction complex and eventual 
degradation of Armadillo (Arm, fly homolog of β-catenin).  The binding of Wg to Fz 
results in association with the low-density
 
lipoprotein receptor-related protein LRP.  This 
inhibits the formation of the destruction complex, allowing Arm to be stabilized and 
translocate into the nucleus where it displaces the transcriptional repressor Groucho from 
the Tcf/Lef effector complex and promotes transcription. 
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 Decapentaplegic pathway 
 Several classes of ligands are classified into the Transforming growth factor 
superfamily of morphogens, including TGF-βs and Bone morphogenetic proteins 
(BMPs), of which the Drosophila signaling molecule Decapentaplegic is one.  Like the 
other growth factor signaling molecules, Decapentaplegic (Dpp) in flies and the TGF-β 
superfamily of ligands in general are essential for proper development of an organism.  
During Drosophila development, Dpp plays a role in dorsal ventral polarity, 
establishment of segmental boundaries, and limb development (Nellen et al., 1994; 
Sekelsky et al., 1995; Tabata et al., 1995; Nellen et al., 1996; Affolter and Basler, 2007).  
TGF-β like ligands have also been implicated in diseases later in life, including cancer 
(Zhu and Kyprianou, 2005; Massagué et al., 2000; Padua and Massagué, 2009).  Dpp 
signaling has also been shown to interact with other growth factor signaling pathways.  
For example, dpp cooperates with hedgehog and wingless during appendage 
development in Drosophila, (Campbell and Tomlinson, 1999; Zecca et al., 1995; 
Wolpert et al., 1998).   
 In general, all members of the TGF-β superfamily of signaling molecules are 
cytokines that contain six conserved cysteine residues (Sun and Davies, 1995).  After a 
TGF-β ligand initiates signaling by binding to and bringing together type I and type II 
receptor serine/threonine kinases on the cell surface, the type II receptor is able to 
phosphorylate the receptor I kinase domain (Figure 1.7), which then propagates the 
signal through phosphorylation of various Smad proteins (Kretzschmar et al., 1997; Shi
 
and Massagué, 2004). There are eight Smad proteins which can be categorized into three 
25 
 
 
 
 
 
 
Figure 1.7. The TGF-β signaling pathway.  Generalized representation of Smad 
signaling by TGF-βs (left) and BMPs (right).  Signaling ligands bind to Type II 
receptors, which cause dimerization with and phosphorylation of Type I receptors.  The 
Type I receptors can then phosphorylate  receptor-regulated Smads (Smads 2/3 for TGF-
β, Smads 1/5-8 for BMP), which allows them to form complexes with the Co-mediator 
Smad, Smad 4.  The complex can then regulate transcription of target genes in 
conjunction with various transcription factors (TFs).  Inhibitory Smads (Smads 6/7) are 
able to negatively regulate signaling by targeting receptors for degradation or through 
competitive inhibition. 
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different classes. Receptor-regulated Smads (Smad1, Smad2, Smad3, Smad5, and 
Smad8) are phosphorylated and activated by the type I receptor kinases and form 
complexes with the Co-mediator Smad, Smad4 (Wu et al., 2000; Souchelnytskyi et al., 
2001).  Various cellular responses are elicited by the different classes of ligands due to 
the types of Receptor-regulated Smads that are utilized.  Whereas Smad2 and Smad3 
respond to signaling by the TGF-β subfamily of ligands, Smad1, Smad5, and Smad8 are 
used primarily by the BMP growth factor molecules (Kirsch et al., 2000).  The third 
class is the inhibitory Smads (Smad6 and Smad 7), which negatively regulate TGF-β 
signaling by targeting the receptors for degradation or by competing with Receptor-
regulated Smads for interaction with the receptor or Co-Smad (Shi
 
and Massagué, 2003). 
The activated Smad complexes are translocated into the nucleus and, in conjunction with 
other nuclear cofactors, regulate the transcription of target genes such as spalt major in 
Drosophila (Kretzschmar et al., 1999; Shi
 
and Massagué, 2003).  Further modulation of 
Dpp signaling is achieved through HSPGs, which have been shown to regulate 
morphogen diffusion (Belenkaya et al., 2004).  TGF-β signaling is involved in many 
different developmental processes, and the dichotomous impact the pathway has during 
diseases such as cancer is still being clarified. 
 In this section I have reviewed several highly conserved growth factor signaling 
pathways that are crucial during development.  These same pathways play many roles 
during the adult lives of the organisms they helped to form.  Misregulation of these 
signaling pathways has been implicated in many problems beyond development, 
including many carcinomas.  Understanding the mechanisms by which growth factor 
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signaling is regulated in both developmental processes and disease will help to prevent 
some of the complications associated with improper signaling. 
 
Heparan Sulfate Proteoglycans 
 Signaling by growth factors can be affected through interactions in the 
extracellular matrix (ECM).  The ECM is responsible for providing contextual 
information to cells and maintaining structure, but also takes an active role in the 
propagation of growth factor signals (Bissell and Radisky, 2001).  The ECM consists of 
various macromolecules, including integrins, collagen, and heparan sulfate 
proteoglycans (HSPGs).  HSPGs have been shown to play a role in the movement of 
growth factor ligands through the ECM, as well as in ligand/receptor interactions 
(Rapraeger et al., 1991; Gallet et al., 2003).  Thus, heparan sulfate proteoglycans are 
good candidates for studying the regulation of signaling pathways during development 
and disease.  
 
Types of heparan sulfate proteoglycans 
 Heparan sulfate proteoglycans are basal membrane proteins consisting of a 
protein core to which heparan sulfate glycosaminoglycans are covalently attached 
(Nybakken and Perrimon, 2002).  In Drosophila, three types of HSPGs are present on 
the cell surface and in the extracellular matrix (Lin and Perrimon, 2000).  Glypicans  
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Figure 1.8. The major categories of heparan sulfate proteoglycans.  There are three 
general classes of HSPGs.  Perlecan can be secreted into the extracellular matrix or 
remain associated with the cell surface.  The Syndecan protein core spans the cell 
membrane.  Glypicans are attached to the cell membrane by a 
glycosylphosphatidylinositol anchor. 
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(dally and dally-like protein in Drosophila) are bound to the cell membrane by a GPI 
link (Figure 1.8).  The Syndecan protein core spans the cell membrane.  Perlecans (trol 
in Drosophila) are secreted HSPGs that are part of the extracellular matrix (Perrimon 
and Bernfied, 2000, Lin and Perrimon, 2000).  Heparan sulfate chains are formed from 
long, unbranched chains of modified glycosaminoglycan (GAG) sugar residues 
(Nybakken and Perrimon, 2002).  The GAG chains are attached at serine residues on the 
protein core.  Following addition of a Xylose residue, two galactose residues are added 
to the forming GAG chain (Prydz and Dalen, 2000).  The tetrasaccharide linker region of 
the GAG chain is completed following addition of a glucuronic acid.  Polymerization of 
the heparan sulfate chain continues with the addition of repeating disaccharides of N-
acetyl glucosamine and glucuronic acid (Nybakken and Perrimon, 2002, Prydz and 
Dalen, 2000).  Modification of the sugar chain is then controlled by the N-
deacetylase/N-sulfotransferase enzyme and various sulfotransferases (Nakato and 
Kimata, 2002).  Sulfation can occur at the acetyl group, 2, and 6 positions of N-acetyl 
glucosamine, as well as the 2 and 3 positions of glucuronic acid.  Thus, the heparan 
sulfate chains of HSPGs are extremely variable.  A single heparan sulfate chain can 
include different regions containing either high or low levels of modification and 
sulfation (Nakato and Kimata, 2002).  This variability gives each HS chain the potential 
of containing numerous growth factor binding sites.  The regions of the HS chains may 
be modified to target certain growth factors at specific times and locations during 
development.   The diversity both within and among heparan sulfate chains, coupled 
with their large size, enhances the ability of HSPGs to modulate growth factor signaling. 
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Heparan sulfate proteoglycan modulation of growth factor pathways 
 Heparan sulfate proteoglycans have been shown to play several diverse and vital 
roles in both the transport of growth factor ligands and the transmission of their signals 
(Hacker et al., 2005).  Early studies in Drosophila demonstrated the importance of the 
GAG chains for proper signaling.  Disruption of heparan sulfate chain synthesis by 
mutating the tout velu (ttv) enzyme, or altering modification of the sugar chains by 
sulfotransferase enzyme mutation, leads to improper signaling and development (The et 
al., 1999, Bellaiche et al., 1998).  ttv was also shown to be important in long range 
Hedgehog signaling in the Drosophila wing imaginal disc (Bellaiche et al, 1998).  
Genetic interaction studies have further shown the importance of HSPGs during growth 
factor signaling (Desbordes and Sanson, 2003; Borneman et al., 2004).  Various 
signaling pathways, including Hedgehog, Wnt, and TGF-β, are all affected by mutation 
of HS synthesis or modification enzymes (Giraldez et al., 2002, Selleck, 2001, Tsuda et 
al., 1999, Jackson et al., 1997).  HSPGs also are important in the proper transport of 
signaling molecules through the ECM.  Hedgehog growth factors may rely on HSPGs 
for appropriate distribution of the morphogen (Gallet et al., 2003).  Heparan sulfate 
proteoglycans have also been shown to act as co-receptors during FGF signal 
transduction (Yayon et al., 1991, Rapraeger et al., 1991).  The presence of heparan 
sulfate leads to increased dimerization of the FGF receptors (Venkataraman et al., 1999).  
These examples illustrate how the appropriate synthesis and modification of heparan 
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sulfate chains, as well as proper structure of the core protein, are essential for the 
modulation of growth factor signaling.   
 The Drosophila gene terribly reduced optic lobes (trol) encodes a product of 
approximately 450 kDa, and contains significant sequence similarity to three of the five 
domains of human Perlecan (Park et al, 2003).  Like other perlecans, Trol is secreted and 
present in the extracellular matrix.  Trol-Hedgehog and Trol-Branchless interactions 
have been isolated using co-immunoprecipitation (Park et al, 2003).  trol has been shown 
to modulate signaling by Hedgehog and Branchless during first instar in the developing 
Drosophila larval brain.  Genetic interaction studies show that combining a weak mutant 
trol allele having no phenotype with heterozygous mutants for either bnl or hh, neither of 
which display a mutant phenotype, leads to a decreased number of proliferating optic 
lobe and central brain neuroblasts (Park et al, 2003).  This demonstrates that Trol, like 
other HSPGs, is important for the modulation of growth factor signaling during 
Drosophila development. 
 In this section, I have reviewed the general types of heparan sulfate 
proteoglycans.  I have given examples of how HSPGs are essential for the proper 
signaling by growth factors.  HSPGs play roles in both the transduction of signals as 
well as transport of molecules, and can act as co-receptors for growth factor ligands.  
The modulation of signaling pathways by proteoglycans is not limited to the 
developmental processes of organisms.  Regulation of signaling by HSPGs can also 
affect processes later in the life of an organism. 
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Model Systems of Disease 
 The growth factor signaling pathways that are necessary for the normal 
development of an organism remain present and active later in life.  After the conclusion 
of development, these signaling pathways are important to many different biological 
processes, including tissue repair, maintenance of stem cells, and homeostasis (Boutros 
et al., 2002; Martin and Parkhurst, 2004; Parisi and Lin, 1998; Palma et al., 2005; Potter, 
2007).  Abnormal signaling by or improper regulation of these developmental pathways 
has been implicated in a variety of different diseases, including many different cancers 
(Li et al., 2003; Cronauer et al., 2003; Bale and Yu, 2001).  Abnormal expression of 
signaling ligands and other pathway components or improper receptor activation may 
allow cells to escape normal regulatory cues.  Furthermore, improper signaling by these 
pathways may aid diseased cells in proliferation and metastasis.  The redundancy of 
growth factor signaling pathways among organisms, as well as the vast knowledge base 
of their roles in developmental contexts, allows model systems to be invaluable tools in 
the study of disease. 
 Many problems are encountered by researchers interested in the study of human 
disease.  Acquiring samples with the appropriate controls, ethical concerns about 
treatments, and other environmental factors all make examining disease in human 
patients problematic.  Additionally, diagnosing a patient early enough to properly 
examine the initial causes of a disease is nearly impossible.  Model systems allow 
researchers to control both the environment and genetic background of samples, and also 
allow for biochemical manipulation and treatments not appropriate outside of Tuskegee.  
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Thus, the use of model systems is vital to the understanding and eventual prevention of 
disease. 
 Countless studies have demonstrated the importance of research in model 
systems to the understanding of human diseases (Brumby and Richardson, 2005).  In 
vitro systems such as cell culture studies allow researchers to perform biochemical and 
genetic manipulations necessary for the understanding of basic mechanisms in disease.  
These studies also simplify controlling for environmental differences.  However, this 
simplicity in in vitro systems often does not allow for examination of more complex 
interactions that a cell may encounter in a whole organism.  Whole organism model 
systems have also been utilized extensively to study disease.  In vivo studies permit 
researchers to control for environmental and genetic factors while still maintaining 
biological context for the cells or tissues they are examining.  Although many 
homologous molecules, pathways, and processes exist between model systems and 
humans, the evolutionary distance between species requires data collected from whole 
organism models to be validated in the context of human disease.   
  
Drosophila as a model for disease 
 Drosophila has been used extensively as a model for development.  The presence 
of evolutionarily conserved processes and pathways has led to many advances in 
knowledge of human biology.  In addition to its use as a model system for development, 
Drosophila has emerged as a model for various types of diseases.  Recently, the fly has 
been used to model human neurodegenerative diseases such as Alzheimer’s, 
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Huntington’s, and Parkinson’s (Feany and Bender, 2000; Shulman et al., 2003; Lu and 
Vogel, 2009).  For example, molecular tools available in Drosophila allowed researchers 
to overexpress a mutant form of human a-synuclein, a gene linked to familial Parkinson's 
disease, which led to recapitulation of the features of the disease in the fly (Feany and 
Bender, 2000).  The ability to control the genetic background and manipulate expression 
of detrimental molecules in Drosophila results in insights that can be applied to humans 
suffering from neurodegenerative diseases.  Fly models of inherited neuromuscular 
diseases such as spinal muscular atrophy, myotonic dystrophy, and dystrophinopathies 
recapitulate many of the key pathologic features of the human diseases (Lloyd and 
Taylor, 2009).  The Drosophila model system is also useful in the study of cancer.  
Many of the same molecules and pathways known to be affected in human cancers are 
present in the fly.  For example, genes known to influence the epithelial to mesenchymal 
transition, a hallmark of cancer, are able to cause metastasis in Drosophila by affecting 
apical basal-polarity in a similar way to that in the disease (Pagliarini and Xu, 2003).  
The ability to manipulate the genetic background and expression pattern of a fly, control 
its environment, and perform genetic screens to uncover the molecules and mechanisms 
associated with disease make the Drosophila model system an invaluable research tool. 
 
Human Prostate Cancer 
 Prostate Cancer is the most commonly diagnosed form of cancer in men.  In 2010 
alone, there is estimated to be 217,730 new cases diagnosed, and 32,050 deaths from this 
disease in the United States (National Cancer Institute).  Studies have shown that two out 
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of every three prostate cancer diagnoses occur in men over the age of 65, making age the 
single biggest risk factor for this disease.  Approximately one out of every six men will 
be diagnosed with prostate cancer in his lifetime.  It is the second leading cause of 
cancer death in males in the US, accounting for 11% of cancer deaths (American Cancer 
Society).  Despite these horrifying statistics, there is a good prognosis if diagnosed early, 
with treatment consisting of radiation or prostatectomy.  Early prostate cancer tumor 
growth is androgen-dependent, allowing this to be a treatment target.  However, 
androgen ablation therapies are not useful indefinitely, having a median response time of 
only one to two years (So et al., 2005).  Furthermore, tumors may reoccur after 
prostatectomy (Feldman and Feldman, 2001).  Prostate cancer becomes androgen-
independent in later stages, which leads to a much less hopeful prognosis.  Androgen-
independent prostate cancer is invasive and metastatic, and has no current treatments. 
   
Prostate development 
 The prostate is an accessory reproductive gland responsible for producing and 
secreting the proteolytic fluid that supports sperm survival.  Normal development of the 
human prostate begins around the seventh week of embryogenesis, when testosterone 
signaling by the testes leads to differentiation of the prostate.  The prostate remains 
developmentally inactive throughout childhood, and during puberty exits quiescence and 
resumes growth.  During this period, its adult secretory function is established.  The 
adult prostate surrounds the urethra underneath the bladder (Figure 1.9A).  The 
epithelium of the prostate consists of luminal secretory cells, epithelial cells, and  
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Figure 1.9.  Location and zones of the human prostate.  (A) The location and 
anatomical position of the human prostate.  (B)  The prostate is sub-divided into three 
main zones: the central zone, the peripheral zone, and the transitional zone.  Most 
prostate cancers originate in the peripheral zone.  Modified from (Abel, 2001), (Ellem 
and Risbridger, 2007), and (De Marzo et al., 2007). 
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neuroendocrine cells, while the stroma is made of muscle cells, fibroblasts, endothelial 
cells, and immune system cells (Feldman and Feldman, 2001).  The gland is subdivided 
into a peripheral zone, a central zone, and a transitional zone (Figure 1.9B). It is mainly 
composed of acini, which secrete into the ejaculatory ducts leading to the urethra.  As 
androgen signaling decreases in the aging male, the prostate begins to atrophy. 
 The improper expression of signaling pathway components has been observed in 
many different forms of carcinomas (Cronauer et al., 2003; Bale and Yu, 2001).  During 
normal prostate development, signaling by the Sonic hedgehog ligand is required for 
epithelial differentiation as well as ductal branching morphogenesis (Freestone et al., 
2003; Berman et al., 2003; Berman et al., 2004).  In fact, several other signaling 
pathways, including the FGF, Wnt, and BMP pathways, have been shown to be 
important during normal prostate development (Settle et al., 2001, Kwabi-Addo et al., 
2004; Yardy and Brewster, 2005).  However, abnormal signaling by growth factors may 
play a role in the progression of the disease.  Studies have shown that TGF-β acts as a 
tumor suppressor early in cancer progression, but it is a tumor promoter in late stage 
carcinomas (Steiner et al., 1994; Wikstrom et al., 1998; Wakefield and Roberts, 2002).  
TGF-β inhibits proliferation and stimulates apoptosis early, but low levels of receptor 
expression and changes in other signaling pathways result in TGF-β being upregulated 
and acting as a tumor promoter (Kyprianou, 1999; Guo et al., 1997; Guo and Kyprianou, 
1998; Guo and Kyprianou, 1999; Kleeff, 1999; Festuccia et al., 1999).  Wnt signaling is 
also increased in advanced, metastatic prostate cancer (Chen et al., 2004).  Sonic 
Hedgehog and its signaling pathway modulator Perlecan have been shown to be 
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upregulated in advanced prostate cancer as well (Sanchez et al., 2004; Datta et al., 2006; 
Datta and Datta, 2006).  The heparan sulfate proteoglycan Perlecan has been shown to 
regulate signaling by Sonic Hedgehog, FGF2, and Vascular Endothelial Growth Factor 
in human prostate cancer cell lines (Datta et al., 2006, Savore et al., 2005).  Abnormal 
expression of these growth factor signaling components in diseased tissue suggests that 
improper regulation or signaling by these developmental pathways may play a role in the 
progression of prostate cancer later in life.  Establishing a model system in which 
signaling pathways and their regulators can be examined during the onset and 
progression of prostate cancer may lead to insights on how better to treat the disease.  
  
Drosophila Prostate Cancer Model 
 Model systems allow researchers to examine aspects of disease that may not be 
easily or ethically achievable in a human patient.  Establishing a model system to study 
how growth factor signaling affects prostate cancer initiation and progression is crucial 
in understanding how the disease can be treated.  Some systems have already been 
created to better understand the mechanisms by which a prostate becomes cancerous.  
However, the complexity and the timing of the disease leads to problems with the model 
systems already in use. 
 Multiple cell line models have been established to study the progression of 
prostate cancer.  Prostate and prostate cancer cell lines have been established to simulate 
the biological progression of the disease.  Individual cell lines have been created that 
have different dependencies on androgen, different invasiveness, and different metastatic 
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potential.  These lines are able to model some of the hallmarks of prostate cancer, and 
can easily be used to study the basic mechanisms of cancer progression.  Cell line 
studies are able to closely control environmental conditions and genetic background, 
helping to reduce some of the complexity associated with the disease.  As with other cell 
culture models, prostate cancer lines have some disadvantages.  The in vitro system may 
only accurately model a single point in the progression of the disease, and interactions 
with other cell types or molecules may not be represented.  These issues require the use 
of a whole organism model system. 
 Several in vivo systems have been established for the study of prostate cancer.  
Several transgenic mouse models have been created that allow researchers to study the 
progression of the disease.  Mouse models that generate invasive and metastatic tumors, 
and allow for tissue specific manipulation of gene expression, have proven useful in the 
study of prostate cancer progression (Roy-Burman et al., 2004).  Another whole 
organism model for prostate cancer, the Lobund-Wistar rat model, can form 
spontaneous, metastatic prostate tumors, and has been valuable in the study of prostate 
cancer and the genes associated with the disease (Pollard, 1998).  Although these animal 
models have yielded much data on prostate cancer progression, difficulties remain with 
the systems.  The mouse and rat models are costly to maintain, and can be exceedingly 
time consuming.  Prostate cancer is an age dependent disease, and formation of tumors 
in these animal models can take years (Pugh et al., 1994).  Studies have also suggested 
that older age correlates with more aggressive phenotypes, and the behavior of diseased 
cells differs between young and old hosts (Alexander et al., 1989; McCullough et al.; 
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1997).  Therefore, an in vivo model system is needed that can reproduce the complexity 
of the disease while still maintaining a practical timeframe for study. 
 
Drosophila as a model 
 The benefits of establishing a short-lived and cost effective model system for the 
study of prostate cancer progression are great.  Drosophila has been used extensively as 
a model for both development and disease, including cancer (Pagliarini and Xu, 2003; 
Brumby and Richardson, 2003).  Signaling pathway components and regulators that 
have been implicated in prostate cancer are present in the fly.  Hedgehog, Branchless, 
Wingless, and Dpp signaling is active in Drosophila, and the pathways are regulated by 
HSPGs. The major prostate cancer risk factor is age, and a suitable model system must 
be able to take this factor into account.  Drosophila has been used extensively as an 
aging model (Helfand and Rogina, 2003).  The specific expression patterns of various 
age-dependent genes have been identified in the fly, and the evolutionary conservation 
of aging pathways has been demonstrated (Rogina and Helfand, 1995; Helfand et al., 
1995, Helfand and Rogina, 2003).  Furthermore, the human PERLECAN gene, which 
maps to a locus associated with increased risk of prostate and brain cancer, is 
upregulated in advanced prostate cancer (Gibbs et al., 1999; Datta et al., 2006; Iozzo et 
al., 1994).  The interaction of Perlecan with growth factors and its influence on signaling 
has been well established in Drosophila (Park et al., 2003).  Relatively short lifespan, 
homologous signaling components and regulators, and prior establishment as an aging 
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and cancer model all indicate Drosophila may be useful as a model for prostate cancer 
progression. 
 To be developed as a practical model for prostate cancer, the fruit fly must 
contain an organ with analogous anatomy, function and molecular markers to that of a 
human prostate.  The Drosophila ejaculatory bulb fits these criteria (Figure 1.10).  Like 
the human prostate, the fly ejaculatory bulb mixes sperm produced in the testes with 
seminal fluid secreted from the gland.  This mixture is then pumped into the ejaculatory 
ducts (Lung and Wolfner, 2001; Ludwig et al., 1991).  Several fly homologs of human 
prostate specific markers are also expressed in the fly ejaculatory bulb.  bagpipe 
(Drosophila Nkx3.1 homolog), -methylacyl CoA Racemase (AMACR), acph-1 
(Prostate-Specific Acid Phosphatase), sprouty (Sprouty1), and shaven (Pax2) are all 
prostate specific markers (Tanaka et al., 1998; Bieberichet al., 1996; Rubin et al., 2002; 
Vihko et al., 1980; Kwabi-Addo et al., 2004; Khoubehi et al., 2001) that are only 
expressed simultaneously in the ejaculatory bulb (Hernandez and Datta, unpublished 
data).  Thus, the Drosophila ejaculatory bulb has comparable anatomy and function to 
the human prostate, and the expression pattern of marker genes mimics that in humans. 
 The importance of growth factor signaling and its modulation by heparan sulfate 
proteoglycans in prostate cancer progression has been demonstrated (Chen et al., 2004; 
Sanchez et al., 2004; Datta et al., 2006).  For the ejaculatory bulb to function as a model 
for prostate cancer progression, the signaling pathways and regulators known to affect 
cancer must also be present in the fly.  The Hedgehog and Branchless ligands are indeed 
expressed in the ejaculatory bulb, and expression levels of target genes associated with  
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Figure 1.10. The basic anatomy of the human and Drosophila male reproductive 
tracts.  (A) The anatomy of the human male reproductive system.  The prostate 
produces seminal fluid, combines sperm from the testes and protein secretions from the 
seminal vesicles, and pumps semen out.  (B) The Drosophila reproductive tract 
resembles that of a human.  The ejaculatory bulb combines sperm from the testes with 
secretions from the accessory glands and other proteins and pumps the mixture into the 
ejaculatory duct. Modified from the SEER training program (SEER Registry Database, 
2010). 
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the growth factors show that signaling is active and changes with the age of the fly.  
Furthermore, expression of HSPGs in the bulb is also observed (Hernandez, unpublished 
data).  The Drosophila ejaculatory bulb therefore expresses some of the same molecules 
known to impact prostate cancer progression in humans.  The ETS transcription factor 
ERG is one of the most consistently and highly overexpressed genes associated with 
prostate cancer (Rostad et al., 2007).  The upregulation of this transcription factor is due 
to a chromosomal rearrangement that places it under the control of an androgen-
responsive prostate gene early during prostate cancer progression, and its altered 
expression may play a role in tumor growth (Iljin et al., 2006; Mehra et al., 2008; King 
et al., 2009; Carver et al., 2009).  The fly homolog of the ERG transcription factor is 
ETS65A.  Another ETS transcription factor in Drosophila is Pointed, of which there are 
two transcripts, P1 and P2.  Both isoforms of Pointed contain an ETS oncogene domain, 
and P2 contains a second evolutionarily conserved domain (Klambt, 1993).   
 
Overgrowth of the ejaculatory bulb 
 In order to function as an effective model for prostate cancer progression, the 
ejaculatory bulb must be able to mimic the overproliferation and tumor formation seen in 
cancer.  Ras-MAPK signaling plays an important role in many different carcinomas, and 
abnormal signaling by FGF and VEGF is critical for progression of prostate cancer.  A 
member of that signaling cascade, Ras, is a known oncogene.  Overexpression of Ras in 
Drosophila can produce overgrowth in larval tissues (Brumby and Richardson, 2003; 
Pagliarini and Xu, 2003). 
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 In Drosophila, Ras can be overexpressed, and Ras-dependent signaling 
upregulated, using a constitutively active form of the molecule, Ras
V12
.   Epithelial 
overgrowth in the ejaculatory bulb can be induced by driving Ras
V12
 during the adult life 
of the fly.  DAPI staining showed an increase in the number of stained nuclei in 
overgrown ejaculatory bulbs, with the distribution of cells being much more 
disorganized than that of control bulbs (Datta, unpublished data).  Overexpression of the 
oncogene Ras increases the signaling activity of the Ras-MAPK pathway, which in turn 
results in expression and activity of its target genes, including pointed.  Thus, driving the 
constitutively active Ras
V12
 may lead to the same result seen in human prostate cancer: 
upregulation of the ETS family of transcription factors.  Engineered overgrowth in the 
Drosophila ejaculatory bulb is a promising model for prostate cancer neoplasia, and may 
be valuable in the study of how signaling affects prostate cancer progression. 
While an engineered overproliferation model can be enormously beneficial, it is 
still an artificial system.  Manipulations made to gene expression may result in 
unplanned and unseen consequences.  Therefore, to study how signaling impacts the 
onset of prostate cancer, a spontaneous model for hyperproliferation would be extremely 
valuable.  A single fly line with un-engineered overgrowth of the ejaculatory bulb 
resembling that of Ras
V12
 has been isolated.  Enlarged bulbs in this line look similar to 
the overgrown Ras
V12
 ejaculatory bulbs.  Genetic analysis of the spontaneous line 
showed that the overgrowth did not track with any single chromosome, suggesting the 
overgrowth phenotype is multigenic, similar to human prostate cancer.  The frequency of 
overgrowth seen in the spontaneous line increases as the flies get older, suggesting there 
45 
 
 
may be an age component to the phenotype (Datta, unpublished data).  The spontaneous 
overgrowth Drosophila line may be an important model for understanding the onset and 
progression of prostate cancer. 
In this section I have reviewed some of the basic hallmarks of prostate cancer.  
The rationale for establishing a short lived model system for the progression of prostate 
cancer was explained.  I reviewed how the Drosophila ejaculatory bulb has similar 
anatomy and function to that of the human prostate, and how expression of markers and 
signaling pathway components in the normal ejaculatory bulb resembles that in humans.  
Furthermore, the presence of spontaneous as well as induced overgrowth in the fly bulb 
was reviewed.  In Chapter III, I will attempt to determine whether ejaculatory bulb 
overgrowth resembles human neoplasia.  I will examine the expression and signaling 
activity of growth factors associated with carcinomas in both induced and spontaneous 
overgrowth in the fly bulb.  The effect of manipulating HSPG expression on this 
overgrowth will also be examined.  I will examine whether ejaculatory bulb overgrowth 
has altered cell proliferation, another characteristic of human tumors.  An early method 
of ejaculatory bulb transplantation will also be demonstrated.  These studies will serve to 
help establish the Drosophila ejaculatory bulb as a viable model for human prostate 
cancer and aging.
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CHAPTER II 
PERLECAN MODULATES SIGNALING BY MULTIPLE GROWTH 
FACTORS DURING DROSOPHILA DEVELOPMENT* 
 
 Growth factor signaling is essential for the development of every organism.  
Nearly every biological process is impacted at some level by growth factor signaling 
pathways.  However, the number of signaling molecules and pathways that work to 
develop and maintain a living organism pale in comparison to the multitude of events 
they influence.  How so few signaling pathways can impact such a diverse and sizeable 
assortment of processes is an interesting question.  Furthermore, the damage that can 
occur when growth factor signaling goes awry is frightening.  One explanation as to how 
signaling pathways can influence so many different processes throughout a lifetime is 
through differential regulation.   
 One way in which developmental pathways can be differentially regulated is by 
heparan sulfate proteoglycans.  HSPGs have been shown to be able to modulate 
signaling by acting as co-receptors (Yayon et al., 1991; Rapraeger et al., 1991) and by 
regulating the diffusion of morphogens (Gallet et al., 2003; Belenkaya et al., 2004).  The  
vast number of ways in which HSPGs can be differently modified (Nybakken and 
Perrimon, 2002) allows them to help growth factors reach that high level of variability in 
 
__________ 
* Portions of this chapter reprinted with permission from Lindner, J. R., Hillman, P. R., Barrett, A. L., 
Jackson, M. C., Perry, T. L., Park, Y., and Datta, S. 2007. The Drosophila Perlecan gene trol regulates 
multiple signaling pathways in different developmental contexts. BMC Developmental Biology 7:121. 
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function. 
 The Drosophila Perlecan homolog Trol has been shown to modulate signaling by 
growth factors during development (Park et al., 2003).  In this chapter, I will examine 
the ability of this heparan sulfate proteoglycan to regulate growth factor signaling in a 
variety of developmental contexts.  The ability of Trol to modulate the same signaling 
pathways in different developmental processes will be assayed.  I will examine the role 
Trol plays in assisting growth factors in impacting various developmental processes in 
Drosophila. 
Heparan sulfate proteoglycans modulate signaling by a variety of growth factors.  
The mammalian proteoglycan Perlecan binds and regulates signaling by Sonic 
Hedgehog, Fibroblast Growth Factors (FGFs), Vascular Endothelial Growth Factor 
(VEGF) and Platelet Derived Growth Factor (PDGF), among others, in contexts ranging 
from angiogenesis and cardiovascular development to cancer progression.  The 
Drosophila Perlecan homolog trol has been shown to regulate the activity of Hedgehog 
and Branchless (an FGF homolog) to control the onset of stem cell proliferation in the 
developing brain during first instar.  Here we extend analysis of trol mutant phenotypes 
to show that trol is required for a variety of developmental events and modulates 
signaling by multiple growth factors in different situations.  Different mutations in trol 
allow developmental progression to varying extents, suggesting that trol is involved in 
multiple cell-fate and patterning decisions.  Analysis of the initiation of neuroblast 
proliferation at second instar demonstrated that trol regulates this event by modulating 
signaling by Hedgehog and Branchless, as it does during first instar.  Trol protein is 
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distributed over the surface of the larval brain, near the regulated neuroblasts that reside 
on the cortical surface.  Mutations in trol also decrease the number of circulating 
plasmatocytes.  This is likely to be due to decreased expression of pointed, the response 
gene for VEGF/PDGF signaling that is required for plasmatocyte proliferation.  Trol is 
found on plasmatocytes, where it could regulate VEGF/PDGF signaling.  Finally, we 
show that in second instar brains but not third instar brain lobes and eye discs, mutations 
in trol affect signaling by Decapentaplegic (a Transforming Growth Factor family 
member), Wingless (a Wnt growth factor) and Hedgehog.  These studies extend the 
known functions of the Drosophila Perlecan homolog trol in both developmental and 
signaling contexts.  These studies also highlight the fact that Trol function is not 
dedicated to a single molecular mechanism, but is capable of regulating different growth 
factor pathways depending on the cell-type and event underway. 
 
Background 
Heparan sulfate proteoglycans (HSPGs) are a family of cell-surface and 
extracellular proteins modified by the attachment of glycosaminoglycan chains.  The 
general structure of the protein core determines the family the HSPG belongs to: 
Syndecans contain a transmembrane domain, Glypicans are tethered to the cell surface 
via a GPI linkage and Perlecans are secreted components of the extracellular matrix.  
Both the protein core and glycan chains play important roles in HSPG function through 
protein-protein and sugar-protein interactions.  Genetic studies, first in Drosophila and 
later in mouse and zebrafish, demonstrated the importance of the heparan sulfate chains 
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on all three types of HSPGs for signaling by multiple growth factors such as the 
Fibroblast Growth Factors (FGFs), Hedgehogs, Wnts and Transforming Growth Factors 
(TGFβs) (reviewed in Lin, 2004).   
Perlecan is the largest member of the HSPG family with a core protein of 
approximately 450kD in size.  Perlecan has been linked to signaling by the heparan-
dependent growth factors FGF2,  Vascular Endothelial Growth Factor (VEGF) and 
Sonic Hedgehog (SHH) in mammalian systems (reviewed in Datta et al., 2006; Iozzo, 
2005).  Studies of Perlecan knock-out mice have demonstrated roles for Perlecan in 
vascular development and chondrogenesis as well as maintenance of basement 
membrane integrity (Arikawa-Hirasawa et al., 1999; Costell et al., 2002; Costell et al., 
1999; Gonzalez-Iriarte et al., 2003).  Additional mammalian studies have revealed 
Perlecan's functions in angiogenesis and carcinogenesis (Datta et al., 2006; Mongiat et 
al., 2003; Sharma et al., 1998; Zhou 2004; reviewed in Datta et al., 2006; Iozzo and San 
Antonio, 2001).  Mutation of Perlecan in humans leads to the muscle tone symptoms of 
Schwartz-Jampel syndrome, possibly through altered excitability of the neuromuscular 
junction and the skeletal abnormalities of Silver-Handmaker syndrome, presumably 
through effects on chondrogenesis (Arikawa-Hirasawa et al., 2002; Arikawa-Hirasawa et 
al., 2001; Nicole et al., 2000).   
Studies of Perlecan in invertebrate model systems have led to additional insights 
into Perlecan function.  The single Perlecan gene in C. elegans is encoded by the unc-52 
locus (Rogalski et al., 1993).  Mutations in unc-52 result in embryonic or adult paralysis 
due to defects in body wall muscle cells (Rogalski et al., 1993; Brenner, 1974; reviewed 
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in Rogalski et al., 2001).  Mutations in unc-52 also enhance cell migration defects 
caused by decreased netrin, FGF, TGFβ or Wnt signaling. In Drosophila, Perlecan is 
encoded by the trol gene on the X chromosome (Park et al., 2003; Voigt et al., 2002), 
which was initially implicated in the control of stem cell division in the developing 
larval brain (Datta, 1995; Datta and Kankel, 1992).  In the larval brain, trol promotes the 
cell cycle progression of mitotically arrested neuroblasts (Caldwell and Datta, 1998; 
Park et al., 2003) through modulation of FGF and Hedgehog signaling (Park et al., 
2003).  These Drosophila studies were the first to link Perlecan to Hedgehog signaling.  
More recently, studies of oogenesis in Drosophila have uncovered a role for Perlecan in 
the maintenance of epithelial cell polarity through interactions with the extracellular 
matrix receptor Dystroglycan (Schneider et al., 2006). 
The many signaling pathways associated with HSPGs in general and Perlecan in 
particular led us to ask what other biological processes may require Perlecan function.  
We used a series of trol mutants to investigate several phenotypes ranging from overall 
developmental progress to specific alterations of stem cell division and hemocyte 
production.  Furthermore, analysis of signaling pathway response genes revealed that 
while mutations in Perlecan decrease signaling in multiple pathways, at least some of 
these effects are tissue specific. 
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Results and Discussion 
Development and lethal phase 
We had previously shown that the viable trol
b22 
and the lethal trol
8
, trol
4
, and 
trol
sd 
alleles form an allelic series of increasing severity based on their onset of 
neuroblast proliferation phenotype in first instar larval brain lobes (Park et al., 2003).  
Identification (Park et al., 2003) and phenotypic analysis of a fifth trol allele, trol
7
, 
revealed that trol
7 
is the strongest allele with respect to the first instar proliferation 
phenotype (Figure 2.1A).  Unexpectedly, trol
7 
mutant larvae appeared healthier overall 
than other trol mutant larvae, suggesting that the order of allelic severity determined by 
analysis of first instar brain lobes would be different from one based on developmental 
progression.  To test this hypothesis, we examined the lethal stage and developmental 
progression of larvae mutant for trol
b22
, trol
8
, trol
4
, trol
sd 
and trol
7
.  In all the 
experiments, crosses were designed to use sibling controls in order to minimize the 
effects of genetic background, which can be significant in fly stocks kept in reproductive 
isolation from each other for years in our laboratory.  For the lethal trol alleles, y trol
x 
/Binsn stocks were used as the source of mutant and control larvae.  At this stage of first 
instar, mutations in y produce one of the few reliable phenotypic markers.  Thus trol 
mutant animals were identified as y mutant larvae that are y trol
x 
hemizygous males and 
sibling controls were a mixed population of y
+ 
animals: y trol
x
/Binsn heterozygotes, 
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Figure 2.1.  Phenotypic series of trol alleles.  (A) First instar neuroblast proliferation 
phenotype presented as % of samples with numbers of BrdU labeled neuroblasts falling 
within the control range, some data originally published in Park et al, 2003a.  (B) Lethal 
phase phenotype presented as the percentage of trol mutant animals capable of survival 
and development to third instar (grey bars) or to pupal formation (black bars) compared 
to sibling controls.  Error bars indicate s.e.m.  (C) Cartoon of second instar larval brain 
with dividing TNBs in ventral ganglion.  Boxed area indicates portion of brain shown in 
panels D-G below.  A = anterior, P = posterior.  (D-G) Examples of the five classes of 
BrdU incorporation into TNbs are shown.  In all panels anterior is to the left, posterior is 
to the right.  Scale bar in panel D indicates 25 um.  (D) None (class 1).  (E) Few (class 
2).  (F) Segmentally repeated lines with few extra neuroblasts (class 3).  (G) Segmentally 
repeated lines with several scattered neuroblasts (class 4).  (H)  Heavily populated 
segmental pattern (class 5). 
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Binsn homozygous females and Binsn hemizygous males. Note that while Binsn 
homozygous females and hemizygous males can become viable adults, not all 
Binsn/Binsn or Binsn/Y larvae reach adulthood.  Thus our comparison provides a 
measure of developmental progression and lethal phase that will err on the side of 
minimizing the trol mutant phenotype.  For analysis of the viable trol
b22 
allele, additional 
crosses were required to produce wild-type sibling controls from the homozygous y 
trol
b22 
stock. y trol
b22 
animals were crossed to the wild-type strain Canton Special (CS) to 
produce trol
b22
/CS heterozygous females.  These females were mated to CS males to 
generate hemizygous y trol
b22 
male larvae and y
+ 
sibling control larvae (a mixture of 
heterozygous y trol
b22
/CS female, homozygous CS female and hemizygous CS male) for 
the developmental studies.  One hundred mutant and sibling control animals for each 
allele were collected at early first instar and monitored at 24 hour intervals for 
developmental progression and viability.  Of these, only 1 mutant trol
4 
and no trol
sd 
animals pupariated.  However, when the same numbers of trol
b22
, trol
8 
and trol
7 
mutant 
larvae were analyzed and compared to sibling controls, 102%, 38% and 23% of the 
animals were able to pupariate, respectively (Figure 2.1B).  The pupariation assay 
resulted in shifts of perceived functional severity for both trol
4 
and trol
7
, with trol
4 
appearing stronger and trol
7 
appearing weaker. 
 Why would animals mutant for trol
7 
(that has a strong effect on neuroblast 
proliferation) be able to progress further in development than animals mutant for trol
4 
which causes a weaker neuroblast proliferation phenotype?  One possibility is that trol 
modulates the activity of different signaling pathways in different tissues.  For example, 
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a mutation that affects the ability of Trol to function in the Hh pathway would have a 
severe effect on developmental decisions that require Hh activity and very little effect on 
decisions that do not require Hh signaling.  To address this possibility we investigated 
the impact of trol mutations on two distinct developmental events and several signaling 
pathways. 
 
Effects of trol mutations on TNb proliferation 
trol was initially identified as a mutation on the X chromosome that affected the 
proliferation pattern of neuroblasts in the brain lobes and ventral ganglion (Datta, 1995; 
Datta and Kankel, 1992).  Since neuroblasts in the thoracic region of the ventral 
ganglion begin proliferation in early second instar (Datta 1995; Truman and Bate, 1988; 
Prokop and Technau, 1991), we evaluated the ability of thoracic neuroblasts (TNbs) to 
enter S phase in trol mutant animals.  We adapted the idea of phenotypic classes to 
produce a scale for the extent of TNb proliferation at four hours post molt (Figure 2.1C-
G).  Five TNb classes were defined as follows: Class 1, no neuroblasts labeled; Class 2, 
a small number of labeled neuroblasts with no distinct segmental pattern; Class 3, 
labeled neuroblasts in a segmentally repeated lines with very few labeled neuroblasts in 
between the lines or in the medial region of the ventral ganglion; Class 4, labeled 
neuroblasts in a segmentally repeated line with some labeled neuroblasts in between the 
lines or in the medial region of the ventral ganglion; and Class 5, labeled neuroblasts in 
heavily populated segmental pattern with many labeled neuroblasts in the medial portion 
of the ventral ganglion.  When both sides of a ventral ganglion did not conform to a 
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single class, the sample was scored as the higher class.  This will have a conservative 
effect of scoring a partial loss-of-proliferation TNb phenotype as more wild-type.  Thus 
we can have greater confidence in the significance of TNb proliferation phenotypes 
observed compared to controls. 
We first examined the onset of TNb proliferation in wild-type sibling controls to 
determine the time point at which to assay the trol mutants (data not shown).  In our 
hands, high levels of 5-Bromodeoxyuridine (BrdU)-labeled TNbs were first observed in 
control samples between 2–5 hours post molt depending on genetic background.  This 
timing is slightly earlier than the previous observation that TNb mitosis begins between 
28–34 hours post hatching, or 4–10 hours post molt (pm) to second instar (Truman and 
Bate, 1988).  To evaluate the TNb proliferation phenotype produced by the different trol 
alleles, at least twenty samples for each mutant and sibling control (generated as 
described above) were allowed to incorporate BrdU from 4–5 hours pm and scored for 
TNb class.  The average score and standard error of the mean were calculated for each 
group of sibling controls.  The control value for each study was set to a value of 4 to 
control for genetic background effects between experiments. Setting controls to a value 
of 4 on our 5 point scale was chosen to allow evaluation of over-proliferation (>4) as 
well as under-proliferation (<4) mutant phenotypes.  To obtain the TNb phenotype score 
for each mutant allele we normalized the score for each sample to the respective sibling 
control and calculated the average and standard error of the mean (Table 2.1).  
Surprisingly, trol
b22 
mutants had a significantly higher than normal level of TNb 
proliferation (TNb score >4) while the  
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Table 2.1. TNb BrdU incorporation phenotype of trol mutants at 4–5 hours pm.  
Each mutant allele scored for thoracic neuroblast proliferation and compared to the 
respective sibling control.   
 
 
 
trol allele TNb score* S.E.M. 
 
Control 4.00 0.27 
trolb22 4.55 0.16 
trol8 3.37 0.21 
trol4 3.00 0.27 
trol7 2.95 0.2 
trolsd 2.45 0.21 
 
* All scores significantly different from controls at p < 0.05. 
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remaining trol mutants showed decreased TNb cell division compared to controls.  The 
differences between mutant and control BrdU incorporation were statistically significant 
(p < 0.05) for each mutant allele.  Comparison between mutants showed a phenotypic 
trend from trol
b22 
having hyperactive TNb proliferation to trol
sd 
as the mutant with the 
fewest labeled TNbs.  In this assay trol
7 
mutants appear to have a weaker phenotype than 
trol
sd
. 
The relatively minimal differences in severity observed between the first and 
second instar neuroblast proliferation phenotype in the various trol alleles contrasts with 
the more dramatic differences observed in the developmental assays.  One possible 
explanation is that the two spatially and temporally distinct classes of neuroblasts might 
have similar requirements to activate their proliferation.  Trol is able to modulate both 
Hh and Bnl signaling, and first instar neuroblasts require signaling by these growth 
factors to exit quiescence (Park et al., 2003; Barrett et al., 2008).  To determine if similar 
cues are used by the two different populations of neural stem cells, we asked if the same 
pathways are also involved in the activation of TNb proliferation in second instar. 
 
hh and bnl signaling in the second instar ventral ganglion 
 We used lacZ insertions in bnl (bnl
06916
) and hh (hh
P30
) to follow the spatial and 
temporal pattern of expression of these two growth factors in the ventral ganglion during 
early second instar (Figure 2.2A-E).  ß–galactosidase activity staining revealed that both 
ligands are expressed in the ventral ganglion from the time of molting to second instar 
through 4 hours pm, the period during which the TNbs are resuming proliferation.  ß–  
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Figure 2.2. Timecourse of hh expression, MAPK and Hh signaling activity and 
BrdU incorporation in the ventral ganglion.  hh expression as monitored by β- 
galactosidase staining using the hh
P30
 allele at (A) 0 hours pm; (B) 1 hour pm; (C) 2 
hours pm; (D) 3 hours pm and (E) 4 hours pm. The pattern of MAPK activity as assayed 
using the MAPK-GAL4/Vp16 system in the ventral ganglion at (F) 0 hours pm; (G) 1 
hour pm; (H) 2 hours pm; (I) 3 hours pm and (J) 4 hours pm.  The pattern of Hh 
signaling activity as monitored by ptc-lacZ in the ventral ganglion at (K) 0 hours pm; (L) 
1 hour pm; (M) 2 hours pm; (N) 3 hours pm and (O) 4 hours pm.  BrdU incorporation in 
the ventral ganglion at (P) 0-1 hour pm; (Q) 1-2 hours pm; (R) 2-3 hours pm; (S) 3-4 
hours pm and (T) 4-5 hours pm. 
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galactosidase activity staining showed expression of both hh-lacZ and bnl-lacZ, although 
bnl-lacZ was considerably lighter (data not shown).  Neither the spatial pattern nor the 
intensity staining representing expression of either growth factor changed appreciably 
during this time period. 
To determine if expression of the bnl and hh ligands resulted in signaling 
activity, we used reporter constructs to follow Bnl and Hh pathway activation.  Bnl 
signaling occurs through the Ras-MAPK pathway, and we have shown in first instar that 
inhibition of MAPK activation inhibits neuroblast proliferation (Park et al., 2003). We 
followed MAPK activity in the ventral ganglion with a MAPK-GAL4/Vp16 fusion that 
can transcribe a UAS reporter gene only upon phosphorylation of MAPK and 
subsequent translocation of the fusion protein into the nucleus (Kumar et al., 2003).  ß–
galactosidase activity produced by a nuclear localized UAS-GFPlacZ.nls reporter gene 
was assayed since ß–galactosidase activity can be detected in significantly less time than 
GFP using this system.  Our timecourse shows that nuclear MAPK activity is high 
within the thoracic region of the ventral ganglion from 0 to 2 hours pm, followed by a 
decline.  MAPK activity peaks at 1 hour pm, approximately 3-4 hours prior to the onset 
of maximal TNb proliferation in controls (Figure 2.2F-J).  This is in general agreement 
with culture studies in first instar where addition of a MAPK inhibitor 6 hours prior to 
BrdU incorporation assays greatly diminished the number of neuroblasts that labeled 
with BrdU (Park et al., 2003).  While MAPK is also activated by other growth factors 
such as EGF, our genetic studies indicate a functional role for Bnl in the activation of 
TNb proliferation.  To examine Hh pathway activity, we used a lacZ reporter gene for 
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the Hh response gene ptc (ptc-lacZ).  ß–galactosidase activity driven by ptc-lacZ was 
also high in the ventral ganglion from 0-1 hrs pm, and then decreased at later timepoints 
(Figure 2.2K-O).  Peak ptc-lacZ expression in the thoracic region of the ventral ganglion 
was observed at 1 hour pm, similar to the MAPK activation reporter.  Taken together, 
our data indicate a dynamic pattern of signaling activity as monitored by MAPK and ptc 
response during early second instar, in contrast to the relatively constant pattern of 
expression of the presumed ligands Bnl and Hh. In the case of MAPK, it is possible that 
some of the changes in pathway activity are due to the presence of other activating 
ligands.  In the case of ptc-lacZ, it is clear that another mechanism besides 
transcriptional regulation of hh must be acting to control pathway activity.  Our ligand 
expression and signaling activity data suggest that Bnl and Hh signaling are occurring in 
the thoracic region of the ventral ganglion, but the question of whether the signaling is 
required for control of TNb proliferation remained. 
 To ask if Hh and Bnl signaling activated TNb proliferation, we first examined the 
effect of ligand over-expression or decreased ligand activity on TNb proliferation.  
When a hs-hh line was reared at 25C to over-express hh, more TNbs incorporated BrdU 
at 0-1 hrs pm compared to control animals (Figure 2.3A-B).  In contrast, homozygous 
hh
ts2
 animals raised at 18C through embryogenesis and then transferred to 25C upon 
larval hatching clearly showed a diminished number of BrdU labeled TNbs at 2-3 hrs pm 
compared to control heterozygous individuals (Figure 2.3C-D).  To allow over-
expression of bnl, animals carrying hs-GAL4 and UASbnl were raised at 18C during 
embryogenesis and moved to 25C upon larval hatching.  Over-expression of bnl resulted  
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Figure 2.3. Hh and Bnl signaling affect TNb proliferation.  One hour BrdU 
incorporation in TNbs in (A) a hs-hh brain from 0-1 hour pm; (B) a control CS brain 
from 0-1 hour pm; (C) hh
ts2
 brain from 2-3 hours pm; (D) a control hh
ts2
 / + brain from 
2-3 hours pm; (E) a hs-GAL4 / +; + / UAS-bnl brain at 23-24 hours ph first instar; (F) a 
control hs-GAL4 brain from 23-24 hours ph first instar; (G) a bnl
06916
 brain from 2-3 
hours pm and a H) control bnl
06916
 / + brain from 2-3 hours pm. 
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in excess BrdU labeled TNbs as early as 23-24 hrs ph or late first instar compared to hs-
GAL4 controls (Figure 2.3E-F).  Conversely, animals homozygous for the partial-loss-
of-function allele bnl
06916
 showed decreased numbers of BrdU labeled TNbs at 2-3 hrs 
pm compared to heterozygous controls (Figure 2.3G-H).  This data indicate that both Bnl 
and Hh signaling are required for the normal onset of TNb proliferation during second 
instar.  trol mutations also affect TNb proliferation, suggesting that trol may modulate 
Bnl and Hh signaling in the second instar brain as it does during first instar. 
To test whether the neuroblasts themselves are responding to the Hh and Bnl 
signaling, or whether they are receiving the signals indirectly from other cells in the 
ventral ganglion, we performed double labeling experiments during early second instar.  
We used a FLP-out system which allowed the cells responding to Hh or Bnl signaling to 
be permanently labeled.  To do this, UAS-FLP recombinase enzyme was driven by 
either MAPK-GAL4 or ptc-GAL4, which targeted a FRT actin-lacZ reporter.  Any cell in 
which MAPK or Hh signaling had occurred would then be permanently marked by the 
expression of lacZ under the actin promoter.  Labeling with BrdU from 4-5 hrs pm and 
staining for both BrdU and lacZ showed lacZ expressing cells near but not overlapping 
with BrdU incorporated cells (Figure 2.4).  Therefore, cells adjacent to proliferating 
neuroblasts are responding to Hh and Bnl signaling, and both act indirectly to regulate 
re-activation of thoracic neuroblasts. 
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Figure 2.4.  Hh and Bnl signaling occurs in cells adjacent to thoracic neuroblasts.  
(A) Proliferating cells labeled with BrdU (black arrows) are adjacent to MAPK signaling 
cells, labeled with lacZ (blue arrows).  (B)  Proliferating neuroblasts labeled with BrdU 
are adjacent to ptc expressing cells labeled with lacZ.  Cartoon shows region of the 
larval brain pictured. 
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trol affects Bnl and Hh signaling in the ventral ganglia 
To determine if trol affects TNb proliferation through modulation of Bnl and Hh 
signaling, we used genetic interaction studies with the weak trol allele trol
b22
.  As we 
have shown, trol
b22 
animals have over proliferation of TNbs compared to sibling controls 
(Table 2.1).  For the genetic interaction assay, y trol
b22 
females were crossed to 
bnl
06916
/TM3y
+ 
males to generate y larvae that were y trol
b22 
; bnl
06916
/+ and y
+ 
sibling 
controls that were a combination of y trol
b22 
; +/TM3y
+ 
males, y trol
b22
/+ ; +/TM3y
+ 
females and trol
b22
/+ ; bnl
06916
/+ females.  None of the sibling controls had TNb 
proliferation scores outside of the normal (CS) range at this timepoint. y trol
b22 
males 
carrying a single copy of the bnl
06916 
allele had fewer BrdU labeled TNbs at 2–3 hours 
post molt to second instar (pm) compared to siblings that were hemizygous or 
heterozygous for trol
b22 
alone or heterozygous for both trol
b22 
and bnl
06916  
(Figure 2.5).  
The decreased TNb proliferation in samples heterozygous for bnl
06916 
in a trol
b22 
background compared to controls versus the increased proliferation in trol
b22 
animals 
wild-type for bnl compared to controls suggests that the trol
b22 
mutation affects signaling 
by Bnl in the ventral ganglion at second instar. 
We also used genetic interactions to evaluate the possibility that trol might affect 
Hedgehog signaling in the ventral ganglion.  For this study y trol
b22 
females were crossed 
to hh
AC 
/TM3y
+ 
males to generate y larvae that were y trol
b22 
; hh
AC
/+ and y
+ 
sibling 
controls that were a combination of y trol
b22 
; +/TM3y
+ 
males, y trol
b22
/+ ; +/TM3y
+ 
females and trol
b22
/+ ; hh
AC 
/+ females. trol
b22 
animals carried a single copy of the hh
AC 
allele, also had fewer dividing TNbs at 2–3 hours pm compared to sibling controls  
65 
 
 
 
 
 
 
 
 
Figure 2.5.  Trol modulates Hh and Bnl signaling in the ventral ganglion.  (A)  
Cartoon of second instar brain indicating location of TNbs.  Boxed area outlines thoracic 
region shown in panels B-E.  One hour BrdU incorporation in TNbs in (B) a y trol
b22
; 
bnl
06916
/+ brain from 2–3 hours pm; (C) a sibling control y trolb22/+ ; +/TM3y+, y trolb22 ; 
+/TM3y
+ 
or y trol
b22
/+ ; bnl
06916
/+ brain 2–3 hours pm (see text); (D) a y trolb22; hhAC/+ 
brain from 2–3 hours pm and a (E) sibling control y trolb22/+ ; +/TM3y+, y trolb22 ; 
+/TM3y
+ 
or y trol
b22
/+ ; hh
AC 
/+ brain from 2–3 hours pm (see text). Scale bar in panel A 
indicates 10 um. 
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(Figure 2.5).  The decrease in the number of BrdU labeled TNbs in trol
b22 
hemizygotes 
upon heterozygosity for hh
AC 
suggest that mutations in trol also weaken the signaling 
action of Hh in the ventral ganglion.  To further test our hypotheses, we examined the 
signaling activity of Bnl and Hh in trol mutants directly by quantitative RealTime PCR 
(qRT-PCR) in the central nervous system (CNS).  To avoid interfering signals from the 
lobes of the second instar brain that might overwhelm differences in signal in the ventral 
ganglion, we isolated ventral ganglia from second instar trol mutant and sibling control 
brains at one hour post molt.  First instar brains were dissected at 20 hours post hatching 
which correlates with the end of the BrdU labeling period used to assess neuroblast 
proliferation in first instar (Park et al., 2003; and this manuscript).  RNA was isolated, 
cDNA synthesized and amplified and the level of expression of the Hh response gene ptc 
(Figure 2.6) and the Bnl response gene pnt (Figure 2.6) assayed.  Our qRT-PCR data 
demonstrate that mutations in trol affect the strength of signaling by both Hh and Bnl in 
the larval ventral ganglion and in first instar larval brains (data not shown). 
 
Trol localization in the larval brain 
Previously we had isolated complexes containing either Trol and FGF2 or Trol 
and Hh by co-immunoprecipitation (Park et al., 2003).  In combination with our genetic 
studies, these complexes suggested that the Trol protein regulates neuroblast division by 
binding growth factors that stimulate neuroblast proliferation in a manner similar to 
Perlecan-mediated promotion of ligand-receptor binding described in mammalian 
systems (Aviezer et al., 1997).  This model predicts that Trol protein should be localized 
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Figure 2.6. Hh and Bnl signaling activity in the ventral ganglion of trol mutant 
animals. Quantitative RT-PCR analysis of the expression of the Hh response gene ptc 
(black bars) and the Bnl response gene pnt (grey bars) in the ventral ganglia of trol 
mutant normalized to controls at one hour post molt to second instar. β-actin was used to 
as an internal control to normalize message levels. All analyses were done in triplicate 
and three different concentrations to ensure samples were within linear range of 
amplification. Error bars indicate standard deviation. 
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near the regulated neuroblasts, i.e. the optic lobe and central brain neuroblasts of the first 
instar brain (Park et al., 2003; Voigt et al., 2002; Datta, 1995; Datta and Kankel, 1992; 
Caldwell and Datta, 1998; Park et al., 2003; Park et al., 1998) and the thoracic region of 
the second instar brain (Datta and Kankel, 1992; and Figure 2.7A).  In contrast, in situ 
hybridization studies in the third instar larval brain by Voigt et al (Viogt et al., 2002) had 
revealed that only a few isolated cells at a distance from the optic lobe proliferation 
centers express trol.  This led the authors to suggest that Trol is unlikely to regulate 
neuroblast proliferation by promoting binding of FGF-type ligands to their receptors 
since this would require Trol protein localization near the responding cells.  However, 
since Trol is a secreted protein with a long half-life, mRNA expression patterns may not 
accurately portray protein localization. In addition, Voigt et al conducted their in situ 
analysis at late third instar, 2–3 days after the activation of neuroblast division at late 
first or early second instar.  Thus the expression pattern observed for trol message at late 
third instar may not reflect expression of trol at earlier larval stages.  Furthermore, a 
study of trol mRNA localization by in situ hybridization in embryos showed either no 
obvious staining in the CNS (Friedrich et al., 2000) or expression in a small subset of 
glial cells in the CNS (Viogt et al., 2002).  However, analysis of Trol protein localization 
with an anti-Trol antibody in embryos revealed localization to the basement membrane 
of the CNS (Friedrich et al., 2000).  This evidence further suggests that trol message 
patterns may not reflect Trol protein localization.  To address the conflicting models, we 
took advantage of a Trol protein trap in which the GFP gene is inserted within the 
endogenous trol locus (Medioni and Noselli, 2005).  Analysis of GFP localization in 
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larval brains demonstrates that Trol-GFP is found in a layer, presumably the basal 
lamina, encompassing the entire outer surface of the larval brain with little to no signal 
detectable at internal sites within the brain (Figure 2.7B-E).  Trol-GFP was also 
observed in the basal lamina surrounding nerves emanating from the larval brain.  The 
distribution of Trol over the entire brain was further verified by immunohistochemistry 
using an anti-Trol antibody (Figure 2.7F).  This localization of the Trol protein is 
consistent with the model that Trol binds Bnl and Hh and facilitates their signaling to 
promote neuroblast proliferation, as the regulated neuroblasts are found at the surface of 
the cellular cortex in both the brain lobes and the ventral ganglion (Datta, 1995; Truman 
and Bate, 1998; White and Kankel, 1978).  To determine if the localization of Trol-GFP 
to the basal lamina was unique to the larval brain, we examined Trol-GFP in the salivary 
glands.  As in our larval brain studies, Trol-GFP is found on the surface of the gland, 
presumably as a component of the basal lamina (Figure 2.7G).  
 
Effects of trol mutations on larval hemocyte number 
A second system where we thought trol might have an effect on development is 
the production of hemocytes during larval life.  A number of studies have elegantly 
shown that the larval lymph gland is the source of larval hemocytes (Evans et al., 2003).  
In the primary lobe of the third instar lymph gland prohemocytes arise in the medullary 
zone while maturing hemocytes are found in the adjacent cortical zone.  Hemocytes are 
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Figure 2.7. Localization of Trol-GFP in the larval brain. (A) Schematic of neuroblast 
position in the larval brain. A = anterior, P = posterior, ONbs = optic lobe neuroblasts, 
CNbs = central brain neuroblasts, TNbs = thoracic neuroblasts.  In panels B-F, Anterior 
is to the left, Posterior is to the right.  (B) Optical section of Trol-GFP brains at first 
instar, brain surface, scale bar indicates 10 um for both panels B and C.  (C) Trol-GFP 
localization in first instar internal section. (D)  Trol-GFP localization in second instar 
internal section, scale bar indicates 15 um. (E)  Trol-GFP localization in third instar 
internal section, scale bar indicates 25 um. (F)  First instar brain stained with anti-Trol 
antibody, showing staining over the entire surface of the brain.  Scale bar indicates 10 
um. (G)  Trol-GFP localization in internal section of third instar salivary gland. Scale bar 
indicates 25 um. 
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then released into the hemolymph and are present as three types of circulating cells: 
plasmatocytes (95%), lamellocytes (1–5%) and crystal cells (rare).  Each cell-type has 
characteristic morphology and can be easily identified under a compound microscope.  
Mature circulating larval hemocytes are still undergoing cell division, albeit at a low 
rate, as shown by staining of hemocytes with phosphohistone H3, an M phase marker 
(Asha et al., 2003; Qiu et al, 1998).  Expression of an activated Ras (Ras
v12
) in 
circulating hemocytes increases the percentage of circulating hemocytes that stain for 
phosphohistone H3 and results in a 40-fold increase in the number of hemocytes through 
activation of the Ras-MAPK pathway (Asha et al., 2003).  The Ras-MAPK pathway is 
activated by Vascular Endothelial Growth Factor (VEGF) and Platelet Derived Growth 
Factor (PDGF) among others.  Signaling by mammalian homologs of both growth 
factors has been linked to mammalian Perlecan (Iozzo, 2005).  Furthermore, studies of 
PDGF/VEGF receptor (PVR) in Drosophila revealed that PVR is expressed in 
plasmatocytes and that decreased PVR function leads to increased hemocyte cell death 
(Evans et al., 2003).  Thus it seemed likely that mutations in trol could decrease 
PDGF/VEGF signaling in circulating plasmatocytes, resulting in decreased numbers of 
circulating plasmatocytes in trol mutants.  To address this hypothesis, we determined the 
relative number of circulating plasmatocytes in third instar trol
b22 
or trol
7 
and sibling 
control larvae (Figure 2.8A).  Our analysis demonstrates a significant (p < 0.05) drop in 
the number of plasmatocytes in trol mutant versus sibling control larvae. 
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Figure 2.8. Mutations in trol decrease circulating plasmatocyte number and pnt 
expression. (A) Quantification of circulating plasmatocytes in trol
b22 
and trol
7 
mutants 
compared to controls. Each sample consisted of hemolymph pooled from three third 
instar larvae. Five squares were counted for each sample. Each genotype was analyzed in 
triplicate. (B) Brightfield image of plasmatocytes from Trol-GFP stock. (C) 
Fluorescence image of plasmatocytes from Trol-GFP stock demonstrating presence of 
Trol on plasmatocytes. (D) Expression of the VEGF/PDGF response gene pnt in trol
b22 
and trol
7 
mutant hemocytes compared to sibling controls by qRT-PCR. Samples of 
hemolymph from three third instar larvae of each genotype were pooled, RNA extracted, 
amplified and analyzed. All reactions were carried out in triplicate at three different 
template concentrations to ensure amplification was in the linear range. β-actin was used 
as an internal normalization control. 
73 
 
 
Trol localization and function in hemocytes 
The decrease in the number of circulating plasmatocytes in trol mutants versus 
controls suggested that trol might indeed function to promote Ras-MAPK signaling by 
PDGF/VEGF in circulating plasmatocytes.  This predicts that Trol protein would be 
localized on these plasmatocytes. We used Trol-GFP protein trap to examine the 
plasmatocytes for the presence or absence of Trol protein.  Fluorescence microscopy 
revealed that Trol-GFP is indeed found on circulating plasmatocytes in third instar 
larvae (Figure 2.8B-C), but not in the lymph gland (data not shown). 
This result is consistent with the requirement for Ras-MAPK activation in 
plasmatocytes for plasmatocyte proliferation and for PVR in plasmatocytes to avert 
apoptosis, and supports the hypothesis that Trol modulates PVR-Ras-MAPK signaling in 
plasmatocytes.  The ETS-transcription factor pnt is a MAPK-response gene and will 
drive plasmatocyte proliferation (Zettervall et al., 2004).  Therefore we asked if trol 
mutant plasmatocytes show decreased levels of pnt compared to controls.  Plasmatocytes 
were collected by bleeding third instar trol
b22 
and trol
7 
mutant larvae and sibling 
controls, RNA was extracted and amplified, and subjected to qRT-PCR analysis. qRT-
PCR studies demonstrated that plasmatocytes isolated from either trol
b22 
or trol
7 
mutants 
show decreased expression of pnt compared to controls, further evidence that trol 
modulates Ras-MAPK signaling in plasmatocytes (Figure 2.8D). 
 
 
 
74 
 
 
Trol and other growth factor signaling pathways 
Two other growth factor signaling pathways that have been linked to HSPGs are 
the wingless (wg/Wnt) and decapentaplegic (dpp/TGFβ) signaling pathways.  Both of 
these pathways are active in the developing Drosophila eye disc and/or third instar brain 
along with Hh and Ras-MAPK signaling (Kaphingst et al., 1994; Silver and Rebay, 
2005).  To ask if Trol might modulate the Dpp and Wg pathways we evaluated the 
expression of dpp and wg and their target genes spalt major (salm, de Celis and Barrio, 
2000) and sloppy paired (slp, Bhat et al., 2000), respectively, in second instar ventral 
ganglia and third instar brains and eye discs from trol mutant larvae by qRT-PCR 
(Figure 2.9A-B).  We also assayed expression of hh and its response gene ptc in third 
instar brains and eye discs.  In the trol
b22 
second instar ventral ganglion we observed a 
significant drop in the level of both dpp and wg compared to controls.  The trol
b22 
mutation also resulted in diminished signaling efficiency by both growth factors as 
indicated by a larger drop in the level of their response genes salm and slp compared to 
the ligands themselves.  In contrast, the trol
sd 
mutation decreased only dpp expression, 
but the efficiency of both dpp and wg signaling was impaired.  Thus in the second instar 
ventral ganglion, wild-type function of trol appears to be required for normal signaling 
by hh, bnl, dpp and wg (Figures 2.6 and 2.9A).  The decreased expression of dpp and wg 
in trol
b22 
mutants and of dpp in trol
sd 
mutants may be due to secondary effects on dpp 
and wg expression caused by the changes in Hh and Bnl signaling in trol mutants.  
Alternatively, decreased expression of dpp and wg could be due to positive feedback 
between Dpp signaling and dpp expression and Wg signaling and wg expression,  
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Figure 2.9. Dpp, Wg and Hh signaling are affected in trol mutants in second instar 
brains but not in third instar brain lobes/eye discs.  qRT-PCR analysis of (A) the 
expression levels of dpp, its response gene salm, wg and its response gene slp in the 
ventral ganglia of second instar larvae.  Data for the Hh response gene ptc is shown in 
Fig. 2.3.  (B) Expression levels of dpp, its response gene salm, wg and its response gene 
slp, hh and its response gene ptc in trol
sd 
mutant third instar brain lobes/eye discs.  (C) 
Expression of dpp and salm in hsGAL4/+; +/(EP)dad second instar ventral ganglia and 
hsGAL4 controls.  (D) Expression of wg and slp in hsGAL4/+; +/(EP)sgg second instar 
ventral ganglia and hsGAL4 controls.  In all panels, error bars indicate standard error.  
All reactions were carried out in triplicate at three different template concentrations to 
ensure amplification was in the linear range.  β-actin was used as an internal 
normalization control. 
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respectively.  To test the latter possibility, we blocked Dpp signaling by over-expression 
of daughters against dpp (dad) (Tsuneizumi et al., 1997), and assayed for dpp message 
levels (Figure 2.9C). (EP)dad females were crossed to hsGAL4 males to drive 
expression of dad. Embryogenesis and first instar larval development were carried out at 
18°C to limit expression of dad and inhibition of Dpp signaling at early stages.  Upon 
molt to second instar, larvae were moved to 25°C for one hour to induce expression of 
dad.  Larval brains were dissected and the ventral ganglia harvested for RNA isolations. 
Inhibition of Dpp signaling was confirmed by analysis of salm mRNA levels.  Similarly, 
we inhibited Wg signaling by over-expression of shaggy (sgg), and assayed for wg 
message levels (Figure 2.9D).  Decreased Wg signaling was verified by analysis of slp 
expression levels.  As shown by our qRT-PCR analysis, inhibition of Dpp signaling by 
over-expression of dad resulted in a drop in expression of the dpp ligand itself. 
Inhibition of Wg signaling by over-expression of sgg also produced a drop in the 
expression of wg.  As these studies were conducted in flies wild-type for trol, they 
eliminate the possibility that the decreased expression of dpp and wg in trol mutants was 
due solely to reduced Trol-mediated signaling by Hh and/or Bnl.  These data indicate the 
presence of a positive feedback loop for Dpp and Wg in the ventral ganglion. 
 To determine if Trol is necessary for growth factor signaling in other tissues at 
other stages we assayed for dpp, wg and hh expression and activity in trol
b22 
and trol
sd 
third instar brain lobes and eye discs.  No significant changes in either growth factor 
expression or signaling were observed in trol
b22 
samples (data not shown). In trol
sd 
samples, expression of all three growth factors decreased by 65–85%, as did the 
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expression of their response genes (Figure 2.9B).  The sole exception is wg/slp, where 
wg expression decreased about 65% and slp expression decreased only about 50%.  
These data indicate that mutations in trol do not dramatically decrease the signaling 
efficiency of Dpp, Wg or Hh in third instar brain lobes and eye discs, unlike the effect of 
those same trol mutations in second instar. 
 
Conclusion 
trol and Drosophila development 
We have previously demonstrated that mutations in trol prevent the onset of 
neuroblast division in the first instar brain and that most trol mutations are lethal.  
Mutations in a second gene, anachronism, also affect the onset of neuroblast 
proliferation but in the opposite manner: in anachronism mutants, mitotically regulated 
neuroblasts begin cell division too early (Ebens et al., 1993).  However, when a lethal 
trol mutation was combined with a viable allele of anachronism, the lack of neuroblast 
division was rescued (double mutants exhibited the anachronism phenotype of 
premature neuroblast division) but lethality was not (Datta, 1995).  This outcome 
suggested that trol function is required for other developmental events necessary for 
survival. Further analyses revealed that trol modulates Hh and Bnl signaling in the first 
instar brain (Park et al., 2003).  Here we have demonstrated that trol function is required 
for developmental progression to third instar and for pupariation.  Analogous to its 
function in the first instar brain, trol is required to initiate the division of a second, 
independent and spatially distinct population of neuroblasts in the second instar brain 
78 
 
 
(Table 2.1, Figure 2.1).  This initiation of division is also dependent on Bnl and Hh 
signaling (Figure 2.3).  Both growth factor  ligands are present and signaling in the 
thoracic region at the proper time (Figure 2.2), and Trol is required to modulate their 
signals during neuroblast reactivation (Figure 2.5).  We have also demonstrated that the 
Trol protein is localized to the surface of the brain at all larval stages, which places it in 
close proximity to the regulated neuroblasts.  This localization is consistent with our 
model where Trol regulates Bnl and Hh signaling to cells adjacent to the regulated 
neuroblasts (Figure 2.4) by binding the growth factors directly (Park et al., 2003).  Trol 
protein localization to the basal lamina is not limited to the larval brain, as Trol-GFP 
studies also showed Trol protein in the basal lamina surrounding the salivary glands 
(Figure 2.7G).  trol function is not limited to the nervous system, as mutations in trol 
also diminish the number of circulating plasmatocytes by decreasing expression of pnt, a 
PVR response gene in plasmatocytes (Figure 8).  We speculate that trol may be 
necessary for signaling by the Drosophila PDGF and/or VEGF growth factor, just as 
mammalian Perlecan has been shown to function during angiogenesis (Iozzo, 2005).  
Our studies of Dpp and Wg indicate a positive feedback between dpp expression and 
Dpp signaling and wg expression and Wg signaling in the second instar ventral ganglion.  
Signaling by Dpp and Wg is also dependent on trol in the second instar brain, but not (or 
very little) in the third instar brain lobes and eye discs (Figure 2.9), despite the fact that 
Dpp and Wg signaling are taking place in those tissues.  In fact, even Hh signaling 
appears to be independent of trol in this context.  These results highlight an important 
concept in trol, and indeed, in proteoglycan function: that the Trol protein will be used at 
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different times and places to regulate the signaling of different growth factors.  
Deciphering the role of trol in different developmental decisions will require that we 
examine each event individually, as trol will not necessarily mediate the same molecular 
mechanism each time. 
 
Involvement of HSPGs in growth factor signaling 
The requirement for heparan sulfate proteoglycans in signaling by different 
families of growth factors is well established (Hacker et al., 2005), but what is not yet 
clear is why different organs and tissue types use different HSPGs to modulate these 
signaling pathways.  One possibility is that the specific mechanism(s) through which 
these molecules modulate signaling activity allows for site-specific variations in the 
regulation of signaling activity.  HSPGs with varied amino acid sequence can act in the 
same signaling pathway, such as Syndecan-4 and Perlecan for FGF2 (Aviezer et al., 
1997; Tkachenko et al., 2005) or Glypicans, Syndecan-3 and Perlecan for Hh (Park et 
al., 2003; Hacker et al., 2005; Shimo et al., 2004).  Mutations that affect heparan sulfate 
synthesis or modification strongly affect FGF2 and Hh signaling (Hacker et al., 2005).  
Furthermore, Perlecan isolated from various endothelial cell sources has different 
binding affinities for FGF2 (Knox et al., 2002).  These data initially suggested that the 
protein core of the HSPG might have little to do with signaling specificity and that the 
main functional domain of HSPGs is concentrated in the sequence of the heparan sulfate 
chains. 
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The carbohydrate-centric view is being challenged by studies that indicate a role 
for the protein-protein interactions of HSPGs with growth factors and other signaling 
molecules.  For example, expression of chimeric molecules has shown that the 
cytoplasmic tail of Syndecan is specifically required for FGF2 signaling in addition to its 
heparan sulfate chains (Volk et al., 1999).  Perlecan protein-protein interactions include 
the ability of Perlecan to bind growth factors and extracellular matrix molecules at 
various sites on its protein core.  Further mechanisms that allow for differential 
regulation include processing of HSPGs.  These studies suggest a reason for the use of a 
particular HSPG during an individual developmental decision – the flexibility of 
combining both carbohydrate-based regulation and protein-based regulation of cell-cell 
signaling may make a specific HSPG uniquely suited for a given situation. 
In the context of combined carbohydrate and protein inputs into HSPG function, 
it becomes clear that a given HSPG may be expressed and function in very specific 
contexts that take advantage of its unique regulatory abilities.  It is interesting to note 
that we have connected Perlecan with FGF and Hh signaling in the developing fly brain 
while mouse studies have shown that Perlecan knock-out mice have cerebral cortex 
abnormalities (Costell et al., 1999; Park et al., 2003; Datta, 1995).  trol mutant larvae 
have decreased numbers of circulating hemocytes that are likely due to decreased Ras-
MAPK signaling by VEGF/PDGF.  Perlecan knock-out mice also have defects in 
chondrogenesis and cardiovascular development and mammalian studies have 
demonstrated a role for Perlecan in angiogenesis driven by FGFs, VEGF and PDGF 
(Iozzo, 2005).  Finally, we have shown that Perlecan is required for SHH signaling 
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during human prostate cancer growth (Datta et al., 2006), which reveals a new system 
for the investigation of the mechanism of Perlecan action.  Further analysis of the ability 
of HSPGs to substitute for each other in cell fate decisions and the means by which they 
individually regulate cell-cell communication will lead to a clearer understanding of the 
inputs necessary for cells to carry out a developmental or disease progression. 
  
Methods 
Fly stocks 
Stocks of the viable trol
b22 
allele and the lethal trol
4
, trol
7
, trol
8 
and trol
sd 
alleles 
have been described previously (Park et al., 2003; Datta, 1995; Datta and Kankel, 1992; 
Park et al., 1998).  All trol mutant stocks with the exception of trol
b22 
are y trol
x
w/Binsn 
where the chromosome carrying the trol mutation is marked with y to facilitate 
identification of y trol mutant versus y
+
control larvae.  The trol-GFP protein trap was 
obtained from Dr. Stephane Noselli.  The bnl
06916
 and hh
AC 
were obtained from the 
Bloomington stock center and used to construct y ; bnl
06916
/TM3y
+ 
and y ; hh
AC
/TM3y
+ 
stocks for genetic studies.  The bnl
P1
, hh
P30
, hs-hh, hh
ts2
, ptc-lacZ, UAS-GFPlacZ.nls and 
Canton S were obtained from the Bloomington stock center, Dr. Joan Hooper, Dr. Alan 
Michelson, Dr. Bruce Baker or Dr. Ginger Carney and used as described previously 
(Park et al., 2003).    
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Lethal phase 
Early first instar larvae were collected and placed on apple juice plates with 
yeast.  Each plate initially had 50 mutant or control animals per plate, segregated to 
prevent competition between mutant and wildtype siblings.  Two plates of each genotype 
were examined.  The number and stage of larvae still present on each plate were assayed 
every 24 hours and the survivors transferred to a fresh plate.  Since none of the trol 
mutants with the exception of trol
b22 
produce viable adults, individual animals were 
followed only until pupariation. 
 
Developmental staging 
Developmental synchronization was carried out as previously described (Park et 
al., 2003; Datta, 1995; Caldwell and Datta, 1998; Park et al., 2001).  Flies were allowed 
to lay eggs on apple juice agar plates with fresh yeast overnight or for about 24 hours.  
For staging of synchronized first instar larvae, the plate was first cleared of any larvae 
and newly hatched larvae collected in one hour windows and placed on new apple juice 
plates with yeast at 25°C for aging.  For staging of second instar larvae, late first instar 
larvae were placed on fresh apple juice plates with yeast.  Newly molted second instars 
were collected in one hour windows and placed on apple juice plates with yeast at 25°C 
for aging or dissected immediately. 
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Proliferation assay 
BrdU assays were carried out as previously described (Park et al., 2003; Datta, 
1995; Caldwell and Datta, 1998; Park et al., 2001).  Briefly, animals were fed BrdU-
containing artificial medium for one hour, dissected in PBST and fixed with Histochoice 
(Amresco) for 10 minutes. Brain samples were denatured in PBST-HCl for 30 minutes, 
washed and blocked in PBNT for one hour.  Primary anti-BrdU antibody (Becton-
Dickinson) was added at 1:200 overnight at 4°C.  Samples were washed and incubated 
with HRP-conjugated secondary antibody at 1:400 for 2–4 hours at room temperature.  
Signal was developed using a DAB substrate (Sigma). 
 
Larval hemocyte assay 
Hemocytes from three third instar larvae were harvested using a Pasteur pipette 
pulled to generate a capillary end, pooled and counted on a standard hemacytometer 
slide.  Five 16-square regions were counted for each pooled sample.  Three replicates 
were assayed for each genotype. 
 
Quantitative RealTime PCR 
Whole first instar brains or ventral ganglia dissected from the brains of second 
instar larvae were used for RNA isolation.  For first instar brain samples, total RNA was 
isolated using Trizol (Invitrogen) following manufacturer's directions.  Samples were 
DNAsed and reverse transcribed using oligo dT primers.  The resulting cDNA was used 
to perform quantitative Real Time PCR with SYBR Green dye.  For ventral ganglia 
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isolated during second instar RNA was extracted and the sequences amplified as 
described in (Klebes et al., 2002; Klebes et al., 2005).  Hemocyte studies were carried 
out on pooled hemolymph from three third instar larvae per sample.  RNA was extracted 
and amplified as for ventral ganglia.  All qRT-PCR reactions were carried out in 
triplicate at three different template concentrations to ensure that we were within linear 
template range.  Primer sequences are available upon request.  β-actin expression was 
used as an internal control.  Data were analyzed using the delta-delta calculation method 
to yield fold change compared to controls. 
 
Statistics 
Determination of significance was accomplished by use of Student's t test or 
ANOVA, depending on the design of the study. 
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Proper regulation of developmental pathways is essential both during 
development as well as throughout the lifetime of an organism.  Abnormal signaling can 
have many negative consequences, including lethality during embryogenesis and disease 
later in life.  In this chapter, I demonstrated that the heparan sulfate proteoglycan Trol is 
able to differentially regulate multiple signaling pathways in various developmental 
contexts.  I showed that Trol can modulate the signaling of specific growth factors 
similarly in different developmental processes during Drosophila larval life.  However, 
Trol also has a much different impact on the same signaling pathways in another 
developmental context in the larvae.  Thus, regulation of developmental pathways in 
Drosophila by the heparan sulfate proteoglycan Trol helps to add to the ability of growth 
factors to influence such a wide range of biological processes.  In the next chapter, I will 
examine how aberrant signaling can lead to neoplasia in the Drosophila ejaculatory bulb, 
and how this can model human prostate cancer. 
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CHAPTER III 
 
THE DROSOPHILA EJACULATORY BULB IS A MODEL FOR  
 
PROSTATE CENCER 
 
 
Background 
 This year, over 30,000 men will die from prostate cancer in the United States.  
The American Cancer Society estimates over 215,000 men in this country will be 
diagnosed with the disease in 2010, and the number rises every year.  One out of every 
six men will be told they have prostate cancer sometime in their lifetime.  If caught 
early, prostate cancer has a relatively good prognosis.  In its early stages, the disease is 
androgen-sensitive, and there are several different effective treatment options available.  
However, prostate cancer becomes androgen-independent in later stages, and this 
invasive, metastatic form of the disease has a significantly lower survival rate.  In fact, 
prostate cancer not identified until later stages has a five year survival rate of 31% 
(ACS).  It is therefore tremendously important that the illness be caught early in its 
treatable stages.  Consequently, understanding the steps that lead up to the onset and 
early stages of the disease is invaluable. 
 The biggest risk factor for prostate cancer is age.  Greater than two-thirds of all 
cases diagnosed will be men over the age of 65.  This factor makes the study of prostate 
cancer initiation difficult.  One way in which to study the role of aging in the onset and 
progression of the disease is through the use of model systems.  Mouse and rat model 
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systems that are able to generate spontaneous and metastatic tumors have been used to 
examine some of the features of prostate cancer progression (Roy-Burman et al., 2004; 
Pollard, 1998).  However, these systems are costly and time consuming, taking years to 
form tumors (Pugh et al., 1994; Quinn, 2005).  A short lived model system that is able to 
recapitulate the hallmarks of prostate cancer would be immensely beneficial.   
 Drosophila has been widely used as a model for aging.  The fly has become an 
important aging model system due to its quick lifespan and high number of progeny.  To 
go along with the short lifespan, Drosophila also has many of the same aging 
mechanisms as higher organisms.  For example, like other animals, calorie restriction is 
able to increase the Drosophila lifespan by inhibiting the Insulin/Insulin like Growth 
Factor Pathway (Haigis and Guarente, 2006; Tatar et al., 2003).  The availability of 
mutants that alter the lifespan in the fly, like chico, which similarly inhibits the IGF 
pathway, help make Drosophila a relatively simple and useful aging model system 
(Helfand and Rogina, 2003; Bauer et al., 2004).  Furthermore, the lifespan of the fly can 
be precisely altered by adjusting temperature.  Specific expression patterns of various 
age-dependent genes have been identified in the fly, and the evolutionary conservation 
of aging pathways has been demonstrated (Rogina and Helfand, 1995; Helfand et al., 
1995).  The ability to quickly and cost-effectively investigate aging processes similar to 
those in higher organisms, combined with the ability to manipulate gene expression, 
make Drosophila an excellent candidate to study age-related changes leading to the 
initiation of prostate cancer. 
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 Many signaling pathways, such as the Sonic Hedgehog, Fibroblast Growth 
Factor, Wnt, and Transforming Growth Factor-β pathways, have been shown to be 
misregulated in prostate cancers.  Curiously, studies have shown that the ability of 
tissues to respond to growth factor signaling diminishes with age (Cowan et al., 2003).  
Yet, in prostate cancer, increases in growth factor signaling occur despite the disease 
occurring in men of advanced age.  One possibility for the differences in the response of 
diseased tissues to these signaling pathways is heparan sulfate proteoglycans (HSPGs).  
It is possible that altered expression of signaling regulators such as HSPGs may modify 
a cell’s ability to receive growth factor signals.  In the previous chapter, I demonstrated 
how the fly Perlecan homolog Trol is able to regulate signaling by various pathways in 
several different developmental contexts.  The ability of Trol to differentially modulate 
signaling in multiple biological contexts during development suggests that it most likely 
has many roles during processes later in life, such as the initiation and progression of 
prostate cancer.  In fact, Perlecan has been shown to be upregulated in advanced prostate 
cancer samples (Datta et al., 2006).  In this chapter, I will examine the changes in 
heparan sulfate proteoglycan and signaling pathway expression in a short-lived model 
for prostate cancer, the Drosophila ejaculatory bulb.   
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Results and Discussion 
The ejaculatory bulb has similar anatomy, function, and molecular markers as the male 
prostate 
 The benefits of establishing a short-lived and cost effective model system for the 
study of prostate cancer initiation and progression are great.  Drosophila has been used 
extensively as a model for both development and disease, including cancer (Pagliarini 
and Xu, 2003; Brumby and Richardson, 2003; Igaki et al., 2009).  To be an effective 
model for prostate cancer, Drosophila must have an organ with similar anatomy and 
function to that of the human prostate.  In the prostate, sperm produced in the testes is 
mixed with fluid from the seminal vesicles.  The mixture is then pumped out by the 
prostate upon ejaculation.  The Drosophila ejaculatory bulb (EjB) has a very similar 
function and anatomy (Fig 3.1A).  The EjB mixes sperm produced in the testes with 
seminal fluid secreted from the gland and pumps the fluid into the ejaculatory ducts 
(Lung and Wolfner, 2001; Ludwig et al., 1991).  To be a good prostate candidate, the 
EjB should also express similar molecular markers to those found in the human prostate 
(Figure 3.1B).  Dr. Anita Hernandez has shown that the EjB expresses fly homologs of 
human prostate specific markers bagpipe (Drosophila Nkx3.1 homolog), acph-1 
(Prostate-Specific Acid Phosphatase), and shaven (Pax2), as well as the prostate cancer 
biomarkers -methylacyl CoA Racemase (AMACR) and sprouty (Sprouty1) (Tanaka et 
al., 1998; Bieberichet al., 1996; Rubin et al., 2002; Vihko et al., 1980; Kwabi-Addo et 
al., 2004; Khoubehi et al., 2001) (Hernandez and Datta, unpublished data).  Taken 
together, this suggests that the fly ejaculatory bulb is the analog of the human prostate. 
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Figure 3.1. The ejaculatory bulb has similar anatomy and markers to the human 
prostate. (A) The detailed anatomy and connections of the Drosophila ejaculatory bulb.  
(B) PCR amplification off fly cDNA shows expression of the prostate biomarkers 
shaven, acph-1, and bagpipe, and also the prostate cancer biomarkers sprouty and 
AMACR. (Data from Dr. Anita Hernandez). 
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Growth factor signaling and heparan sulfate proteoglycans are important during 
prostate cancer progression (Datta et al., 2006; Chen et al., 2004; Sanchez et al., 2004).  
To reasonably function as a model for prostate cancer, the bulb should also express 
signaling pathway components and modulators known to function in the progression of 
prostate cancer.  Both Branchless and Hedgehog are expressed in the EjB, as well as the 
HSPGs that are known to regulate growth factor signaling (Hernandez, data not shown).  
Signaling by Wnts has been implicated in various cancers, and TGF-β is known to act as 
a tumor-promoter in advanced prostate cancer (Logan and Nusse, 2004; Zhu and 
Kyprianou, 2005).  To examine whether these ligands are present in the normal 
ejaculatory bulb, I looked at expression of the fly Wnt homolog, wg, and dpp, the 
Drosophila TGF-β.  β-galactosidase activity staining on both wg-lacZ bulbs and dpp-
lacZ bulbs 24 days post hatching confirmed the expression of the ligands in EjB (Figure 
3.2).  Therefore, the various signaling pathways that are known to be important in 
prostate cancer, as well as the HSPG’s that modulate their signaling, are present in the 
normal ejaculatory bulb.  We next wanted to determine if the Drosophila EjB could 
recapitulate another hallmark of prostate cancer, neoplasia. 
 
Engineered and spontaneous models of bulb overgrowth 
In order to function as an effective model for prostate cancer progression, the 
ejaculatory bulb must be able to mimic the overproliferation and tumor formation seen in 
cancer.  Abnormal signaling by FGF and VEGF is critical for progression of prostate  
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Figure 3.2.  Expression of wg and dpp in the Drosophila EjB.  ß–galactosidase activity 
staining on wg-lacZ bulb (left) and dpp-lacZ bulb (right).  EjBs were dissected from 
males 24 days post hatching.   
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cancer, and both pathways signal through the Ras-MAPK cascade.  The oncogene Ras is 
a member of that signaling cascade, and overexpression of Ras in Drosophila can 
produce overgrowth in larval tissues (Brumby and Richardson, 2003; Pagliarini and Xu, 
2003). 
 In Drosophila, Ras can be overexpressed, and Ras-dependent signaling 
upregulated, using a constitutively active form of Ras, Ras
V12
.  Driving Ras
V12
 during the 
adult life of the fly causes epithelial overgrowth in the ejaculatory bulb (Figure 3.3A, Dr. 
Suma Datta).  Inducing UAS-Ras
V12
 for 7 days with a heat shock-Gal4 (hsGal4) driver 
leads to a 100% frequency of overgrowth (data not shown).  To test whether the 
overgrowth was due to a greater number of cells being present, DAPI staining was 
performed to determine nuclear distribution.  Staining showed an increase in the number 
of nuclei in overgrown ejaculatory bulbs, with the distribution of cells being much more 
disorganized than that of control bulbs (Figure 3.3B, Dr. Suma Datta).  Although Ras is 
not induced before the adult hatches, it is possible that the additional cells were 
generated during embryogenesis.  To test whether the additional cells were proliferating 
during adult life, I performed 5-bromo2’-deoxy-uridine (BrdU) incorporation and 
staining on the hsGal4 Ras
 V12
-induced flies.  BrdU was applied topically once a day to 
adults undergoing Ras induction.  After 3 days induction/ BrdU application, bulbs were 
stained to visualize nuclei that had undergone S-phase. BrdU incorporation showed cells 
were proliferating during Ras induction (Figure 3.3C, Lindner).  Overexpression of 
oncogenic Ras increases the signaling activity of the Ras-MAPK pathway, which in turn 
results in expression and activity of its target  
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Figure 3.3. Ras induced and spontaneous overgrowth in EjBs. (A) Control 
ejaculatory bulb (left) and Ras
V12
 induced overgrowth after 7 day induction (right) (Data 
from Dr. Suma Datta).  (B) DAPI staining to visualize nuclei in control and Ras induced 
bulbs (Data from Dr. Suma Datta).  (C) Control 3 day BrdU incorporation with no Ras 
induction (left) and 3 day Ras
V12 
induction/BrdU incorporation (right, Lindner). (D) 
DAPI nuclear staining on spontaneous overgrowth EjB.    
 
 
 
 
95 
 
 
genes, including pointed.  Therefore, overexpressing Ras may lead to a similar endpoint 
to that inhuman prostate cancer: upregulation of the ETS family of transcription factors.  
Engineered overgrowth in the Drosophila EjB is a promising model for prostate cancer 
neoplasia, and may be valuable in the study of how signaling affects prostate cancer 
progression. 
Although an engineered overproliferation model can be enormously beneficial, it 
is still an artificial system.  Manipulations made to gene expression may have 
unintended and unseen consequences.  To study how signaling impacts the onset of 
prostate cancer, a spontaneous model for hyperproliferation would be extremely 
valuable.  A single fly line with un-engineered, spontaneous overgrowth of the EjB 
resembling that of Ras
V12
 has been isolated.  Enlarged bulbs in this line look similar to 
the overgrown Ras
V12
 bulbs.  Genetic analysis of the spontaneous line showed that the 
overgrowth did not track with any single chromosome, suggesting the overgrowth 
phenotype is multigenic, similar to human prostate cancer.  The frequency of overgrowth 
seen in the spontaneous line increases as the flies get older, suggesting there may be an 
age component to the phenotype (Datta, unpublished data).  DAPI staining on 
spontaneous overgrowth EjBs 24 days after eclosion results in a similar pattern of nuclei 
seen in Ras
 V12 
induced overgrowth (Figure 3.3D, Lindner), suggesting overgrowth in 
this line is also due to overproliferation of cells in the epithelial layer of the bulb.  The 
spontaneous overgrowth Drosophila line may be an important model for understanding 
the onset and progression of prostate cancer. 
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Signaling in engineered and spontaneous overgrowth EjBs 
 Signaling by the Wnt, Transforming Growth Factor-β, Sonic hedgehog, and 
Fibroblast Growth Factor families of growth factors is critical for the proper 
development of the normal prostate (Freestone et al., 2003; Settle et al., 2001, Kwabi-
Addo et al., 2004; Yardy and Brewster, 2005).  However, misregulation and improper 
signaling by these pathways has been seen in different cancers (Li et al., 2003; Cronauer 
et al., 2003; Bale and Yu, 2001).  For example, TGF-β acts as a tumor suppressor early 
in cancer progression, but it is an oncogene in later stage carcinomas (Steiner et al., 
1994; Wikstrom et al., 1998; Kyprianou, 1999; Guo et al., 1997; Wakefield and Roberts, 
2002).  Sonic hedgehog and its signaling pathway modulator Perlecan have been shown 
to be upregulated in advanced prostate cancer as well (Sanchez et al., 2004; Datta et al., 
2006; Datta and Datta, 2006).  Signaling by Wnt is also increased in advanced, 
metastatic prostate cancer (Chen et al., 2004). 
 To determine if signaling is misregulated in our ejaculatory bulb prostate cancer 
models, I examined gene expression levels of four signaling ligands and their pathway 
response genes.  Newly eclosed hsGal4;UAS-Ras
V12
 males were induced for 7 days at 
30
o
C, followed by isolation of the EjB.  Bulbs were also collected from 7 day aged but 
uninduced control flies.  EjBs from newly eclosed (hatched) flies from the spontaneous 
overgrowth line were collected, as well as overgrown EjBs at 8 days, 16 days, and 24 
days post hatching.  RNA was isolated from the bulbs, cDNA generated, and expression 
levels determined by quantitative real time PCR (qPCR).  Gene expression in the Ras
V12
 
induced overgrowth bulbs was compared to the uninduced control EjBs (Figure 3.4A),  
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Figure 3.4. Signaling in Ras induced and spontaneous overgrowth EjBs.  Gene 
expression levels in ejaculatory bulbs of four signaling pathway ligands and their 
pathway response genes  as determined by quantitative real time PCR.  (A)  Expression 
in Ras
V12
 induced overgrowth bulbs compared to same-aged uninduced bulbs.  (B) 
Expression in spontaneous overgrowth bulbs compared to newly eclosed flies from the 
same line. (C) Expression in the spontaneous line compared at 0, 8, 16, and 24 days to 
same-aged isogenic yw control flies.  Error bars indicate standard deviation. 
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Figure 3.4. Continued. 
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while expression levels in the spontaneous overgrowth bulbs were compared to either 
newly eclosed spontaneous line bulbs (Figure 3.4B) or isogenic yw control EjBs the 
same age as the overgrown bulbs (Figure 3.4C).  Ras
V12
 induced overgrown bulbs 
showed a 4-fold increase in wg expression, with a 2.5-fold increase in its response gene 
slp.  dpp and its signaling readout salm both showed a sharp decrease in expression.  
Expression of the ligands hh and bnl were also down, but expression of the Hh signaling 
pathway readout ptc was not affected.  pnt expression increased, but that is to be 
expected as pnt responds to the Ras-MAPK signaling cascade.  Therefore, induction of 
Ras results in the stimulation of Wg and its signaling pathway, and upregulation of other 
pathways is not necessary for overgrowth in this model. 
           Examining the data from the spontaneous overgrowth bulbs compared to newly 
eclosed 0 day bulbs from the same line shows that expression of most of the signaling 
components either remains the same or decreases as the flies age (Figure 3.4B).  The 
sole exception is the readout for Dpp signaling, salm.  Expression of this gene increases 
approximately 4 to 8 fold over levels at the zero time point.  Although TGF-β acts as a 
tumor suppressor in early prostate cancer, it changes roles and becomes an oncogene 
(Kyprianou, 1999; Guo et al., 1997; Wakefield and Roberts, 2002).  Therefore, this 
upregulation in Dpp signaling resembles what is seen in human tumors.  The decrease in 
Dpp ligand expression while signaling increases suggests that either Dpp signaling is 
more efficient, or another factor is influencing salm.  When compared to yw control 
bulbs of the same age, the pathway response genes for the Wg, Dpp, and Hh pathways 
increase significantly at most timepoints.  Expression of their ligands decreases, 
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suggesting again that another regulator of signaling is positively influencing these 
pathways (Figure 3.4C).  The relative increase in expression for slp and ptc when 
compared to same aged controls suggests that these pathways are being downregulated 
in control EjBs as the flies age.  In the spontaneous line, these pathways remain at the 
same level of signaling, possibly influencing overgrowth.  It is also important to note 
that when compared to same age controls, slp expression is increased at 8 and 24 days.  
Wnt signaling is increased in advanced prostate cancers (Chen et al, 2004).  Therefore, 
the increase in slp observed in both the Ras and spontaneous overgrowth EjBs resemble 
the Wnt upregulation observed in prostate cancer.   
           The differences in expression patterns between each model and the increases in 
pathway readouts independent of ligand expression indicates other factors are affecting 
signaling in the bulbs.  To investigate what other factors might be influencing cell 
proliferation in these prostate cancer models, I looked at other known regulators of 
growth factor signaling. 
 
HSPG expression in engineered and spontaneous overgrowth EjBs 
           Growth factor signaling relies heavily on regulation by heparan sulfate 
proteoglycans.  HSPGs can impact distribution of ligands, as well as act as co-receptors 
in ligand/receptor interactions (Rapraeger et al., 1991; Gallet et al., 2003).  In the 
previous chapter, I demonstrated the role one HSPG, Trol, plays in regulating signaling 
in various developmental processes.  The human Trol, Perlecan, has been shown to be 
upregulated in advanced prostate cancers (Datta et al., 2006; Sanchez et al., 2004), and 
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other HSPGs are also known to impact cancer progression.  Thus, heparan sulfate 
proteoglycans are good candidates for studying the regulation of signaling pathways 
during ejaculatory bulb overgrowth. 
             I examined heparan sulfate proteoglycan expression in a similar fashion as I did 
the signaling pathways.  Overgrowth was induced in Ras
V12
 flies as explained in the 
previous section.  Expression in 7 day Ras induced overgrowth bulbs was compared to 
uninduced controls.  Expression in spontaneous overgrowth bulbs was compared to 
newly eclosed (0 day) same line controls to determine change in expression over time, or 
to yw same-age controls to determine overall changes in gene expression.  In the Ras
V12
 
induced overgrowth line, only trol expression goes up, increasing approximately 40% 
compared to the uninduced controls (Figure 3.5A).  The other HSPGs, dally, dally-like 
protein (dlp), and syndecan (sdc), all showed a significant decrease in gene expression.  
HSPG expression in the spontaneous overgrowth bulbs showed a sharp decrease in 
expression for all four proteoglycans over the 24 days assayed (Figure 3.5B).  However, 
when compared to same aged yw controls, the expression of dally at three of the four 
time points, and most notably syndecan, increased significantly (Figure 3.5C).  syndecan 
expression reached a maximum of approximately an 8-fold increase over controls.  This 
correlates with previous, unpublished data from Dr. Anita Hernandez that showed large 
decreases in HSPG expression in normal ejaculatory bulbs as they aged.  The decrease in 
sdc expression in normal EjBs as they age more than offsets the decrease seen in the 
spontaneous line itself.  The net result is more syndecan being expressed in the 
spontaneous overgrowth line compared to normal aging bulbs.   
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Figure 3.5. HSPG expression in Ras
V12
 induced and spontaneous overgrowth EjBs.  
Gene expression levels in ejaculatory bulbs of four HSPGs as determined by quantitative 
real time PCR.  (A)  Expression in Ras
V12
 induced overgrowth bulbs compared to same-
aged uninduced bulbs.  (B) Expression in spontaneous overgrowth bulbs compared to 
newly eclosed flies from the same line. (C) Expression in the spontaneous line compared 
at 0, 8, 16, and 24 days to same aged isogenic yw control flies.  Error bars indicate 
standard deviation. 
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Figure 3.5. Continued. 
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Prostate specific marker expression in engineered and spontaneous overgrowth EjBs 
 The three prostate specific markers acph-1, bagpipe, and shaven, as well as two 
prostate cancer biomarkers, sprouty and AMACR, are all expressed in the Drosophila 
ejaculatory bulb.  To further investigate how closely our two overgrowth models 
resemble human prostate cancer, I wanted to examine expression of these markers, and 
specifically the two prostate cancer biomarkers, in both the Ras
V12
 and spontaneous 
overgrowth EjBs. 
 I determined gene expression levels of the prostate markers by dissecting and 
collecting ejaculatory bulbs from Ras
V12
 induced flies, uninduced controls, spontaneous 
overgrowth flies at 0, 8, 16, and 24 days post hatching, and aged yw control flies.  In the 
Ras
V12
 induced EjBs, expression of acph-1 decreases slightly, while bagpipe and shaven 
saw a 1.5 and 2-fold increase in gene expression, respectively (Figure 3.6A).  Expression 
of the prostate cancer marker AMACR was halved after a 7 day Ras
V12
 induction.  The 
prostate cancer marker sprouty had a 2-fold increase, although this is most likely 
because sprouty can act as a Ras-MAPK response gene.  In the spontaneous overgrowth 
line, all three prostate markers (acph-1, bagpipe, and shaven) generally decrease over the 
24 days assayed (Figure 3.6B).  The prostate cancer markers are expressed at higher 
levels after 24 days, and AMACR was markedly higher throughout the time assayed.  
This suggests that as the flies in the spontaneous overgrowth line age, the overgrown 
EjBs’ increased expression of prostate cancer biomarkers and decreased prostate marker 
expression allows them to more closely resemble cancerous human prostates than 
normal glands.  When compared to aged yw controls, expression of sprouty 
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Figure 3.6.  Expression of prostate and prostate cancer markers in overgrowth 
EjBs.  Gene expression levels in ejaculatory bulbs of three prostate markers and two 
prostate cancer markers as determined by quantitative real time PCR.  (A)  Expression in 
Ras
V12
 induced overgrowth bulbs compared to same-aged uninduced bulbs.  (B) 
Expression in spontaneous overgrowth bulbs compared to newly eclosed flies from the 
same line. (C) Expression in the spontaneous line compared at 0, 8, 16, and 24 days to 
same-aged isogenic yw control flies.  Error bars indicate standard deviation. 
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Figure 3.6. Continued. 
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at 24 days and AMACR throughout the timecourse remains higher in overgrown bulbs 
than in controls (Figure 3.6C).  Therefore, as the overgrown EjBs begin to resemble 
prostate cancer with an overproliferation phenotype, they also increase expression of 
biomarkers related to the disease. 
 
ETS65A expression in prostate cancer models 
 One of the most consistently and highly overexpressed genes associated with 
prostate cancer is the ETS transcription factor ERG (Rostad et al., 2007).  Upregulation 
of ETS transcription factors stems from a chromosomal rearrangement that places them 
under the control of androgen-responsive promoters active in the prostate early during 
cancer progression (Iljin et al., 2006; Mehra et al., 2008; King et al., 2009; Carver et al., 
2009).  Furthermore, altered expression of ETS transcription factors may play a role in 
tumor growth.  In normal tissue, ETS transcription factors respond to Ras-MAPK 
signaling.  Oncogenic Ras therefore leads to increased expression of the ETS genes.  
However, the chromosomal rearrangement alleviates the need for Ras to promote ETS 
expression, which may lead to cancer progression independent of Ras.  The Drosophila 
homolog of the ERG transcription factor is ETS65A.  I wanted to investigate whether 
this transcription factor that is highly overexpressed in prostate cancer is also 
upregulated in our overgrowth models. 
 I examined gene expression levels of the Drosophila ERG transcription factor 
ETS65A by qPCR.  EjBs were collected from the same lines and at the same timepoints 
as described earlier.  The expression of the transcription factor was five times higher in 
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hsGal4; UAS-Ras
V12
 induced EjBs, which is to be expected since ETS factors are 
upregulated by Ras-MAPK signaling (Figure 3.7A).  More interesting is the expression 
levels in the spontaneous overgrowth line.  ETS65A was upregulated at every time point 
compared to newly eclosed EjBs, almost reaching the same level of relative expression 
seen in the Ras
V12
 induced bulbs (Figure 3.7B).  This is exciting because neither bnl nor 
pnt’s expression is upregulated at any time I assayed in these bulbs, suggesting that 
ETS65A is being positively influenced by other factors in the spontaneous overgrown 
EjBs.  The expression of the transcription factor is also upregulated in later ages when 
compared to same aged control bulbs (Figure 3.7C). 
Another ETS transcription factor in Drosophila is Pointed.  There are two 
different transcripts of pointed, P1 and P2.  Both isoforms of Pointed contain an ETS 
oncogene domain, and P2 contains a second evolutionarily conserved domain (Klambt, 
1993).  To examine whether the ETS transcription factor Pointed could cause 
overgrowth without expression of the constitutively active Ras, I crossed both UAS-pnt 
P1 and UAS-pnt P2 separately to a hsGal4 driver.  After a three day induction, 
overgrowth was seen in 27% of Pnt P1 induced ejaculatory bulbs, and 78% of Pnt P2 
bulbs (Figure 3.8).  After a seven day induction, 54% of Pnt P1, and 100% of Pnt P2 
bulbs were overgrown compared to controls.  At both time points, the thickness of 
epithelial overgrowth was greater in the Pnt P2 samples.  Pnt-induced increases in 
epithelial thickness indicate that EjB overgrowth can be achieved without the 
overexpression of oncogenic Ras, similar to the way in which chromosomal 
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Figure 3.7. ETS65A expression in engineered and spontaneous EjB overgrowth. 
Gene expression levels in ejaculatory bulbs of the ERG transcription factor ETS65A as 
determined by quantitative real time PCR.  (A)  Expression in Ras
V12
 induced 
overgrowth bulbs compared to same-aged uninduced bulbs.  (B) Expression in 
spontaneous overgrowth bulbs compared to newly eclosed flies from the same line. (C) 
Expression in the spontaneous line compared at 0, 8, 16, and 24 days to same-aged 
isogenic yw control flies.  Error bars indicate standard deviation. 
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Figure 3.8. Pointed induced overgrowth in the EjB.  hsGal4 flies were crossed to 
either UAS-Pnt P1 (A) or UAS-Pnt P2 flies to overexpress the ETS transcription factor.  
After a 3 day induction at 30
o
C, 27% of Pointed P1 induced and 78% of Pointed P2 
induced bulbs were overgrown.  After 7 days of induction, 54% of P1 induced and 100% 
of the P2 induced bulbs showed overgrowth compared to uninduced controls.  The PntP1 
overgrowth was generally less severe than in the PntP2 induced EjBs. 
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rearrangements allow ETS transcription factors to influence prostate cancer progression 
independent of Ras in humans. 
 
Age affects the morphology of Ras induced overgrowth 
 Induction and overexpression of Ras
V12
 in newly eclosed to 1 week old flies 
invariably results in uniform overgrowth of the epithelial layer.  However, in bulbs 
where hsGal4 driven UAS-Ras
V12
 induction occurs after 2 weeks of non-induced aging, 
the EjBs begin to show signs of uneven overgrowth.  Aging non-induced flies for 21 or 
28 days prior to the onset of induction increases frequency and extent of irregular 
overgrowth, leading to a drastic variance between the epithelial thickness on either side 
of the ejaculatory bulb (Figure 3.9A).  To examine what may be causing uneven 
overgrowth in flies aged before induction, I used qPCR to assay the expression of 
several different genes in EjBs that had been aged 7, 14, 21, and 28 days before Ras
V12
 
induction, comparing expression levels to bulbs that were not aged before Ras induction 
began (7 day induction starting at 0 days).  I tested the expression of wg and its signaling 
pathway response gene slp.  slp expression is upregulated in both the Ras
V12
 engineered 
overgrowth (Figure 3.4A) as well as the spontaneous overgrowth (Figure 3.4C).  While 
wg expression in the aged samples decreases compared to un-aged induced bulbs, 
expression of the gene remains above levels seen in uninduced controls.  Thus, there 
remains a higher level of Wg ligand available in any Ras induced animal.  Expression of 
the Wg response gene slp is increased when flies are aged before induction, compared to 
flies induced at eclosion.  This upregulation is similar to expression seen in both the 
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Figure 3.9. Overgrowth variability in EjBs aged before Ras induction. (A) EjB 
overgrowth in a fly aged 28 days prior to a 3 day Ras
V12
 induction.  A difference in 
thickness of the epithelial overgrowth on each side of the bulb is seen.  (B) Expression of 
wg, slp, sdc, sprouty, and AMACR in bulbs aged before Ras
V12
 induction compared to 
un-aged Ras induced bulbs.  Error bars indicate standard deviation. 
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un-aged RasV12 induced and spontaneous overgrowth (Figure 3.9B).  This suggests that 
the asymmetric overgrowth seen in flies aged prior to induction is not due to differential 
Wg signaling in older animals.  I also assayed sdc expression, which is highly 
upregulated in the spontaneous but not the un-aged Ras
V12
 induced overgrowth (Figure 
3.5).  Similar to what is seen in un-aged engineered overgrowth, expression of the 
heparan sulfate proteoglycan is decreased.  This continued downregulation of sdc 
suggests that the HSPG is not important for Ras induced ocergrowth at any age.  I also 
tested the two prostate cancer biomarkers sprouty and AMACR.  Both genes are 
upregulated in the aged spontaneous model (Figure 3.6C), but only sprouty expression is 
increased in the Ras
V12
 induced overgrowth (Figure 3.6A).  Compared to the expression 
level in the un-aged Ras
V12
 induced flies, sprouty expression is upregulated in the 7, 14, 
and 21 day timepoints.  This increase in expression compared to uninduced controls in 
all Ras induced bulbs regardless of age is most likely due to sprouty responding to Ras-
MAPK signaling.  AMACR expression is downregulated in all aged time points 
compared to the un-aged induction (Figure 3.9B), which itself had only half the 
expression levels of uninduced controls.  In contrast with the spontaneous overgrowth 
model, the Ras induced model does not appear to resemble human prostate cancer in its 
expression of the AMACR prostate cancer marker.  Taken together, this data suggests 
that flies aged before Ras
V12
 induction have similar expression patterns in the EjBs to 
flies induced immediately after eclosion.  Although still higher than uninduced samples, 
aged bulbs have decreased wg expression, but are able to respond to Wg signaling 
slightly better than un-aged bulbs.  This increase is not due to sdc, as expression of that 
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HSPG declines with age and is not influenced by Ras overexpression.  This indicates 
another untested factor must be responsible for the irregular, uneven overgrowth seen in 
animals aged before Ras induction. 
 
Transplantation of overgrown ejaculatory whether bulbs 
 In order to be a complete model for prostate cancer, the Drosophila ejaculatory 
bulb should be able to model not only neoplasia, but also metastasis.  Studies have 
shown that knocking down the apical-basal polarity genes bazooka and scribbled, 
combined with expression of a constitutively active form of the oncogene Ras, can cause 
metastasis in Drosophila larval tissue (Pagliarini and Xu, 2003; Brumby and Richardson, 
2003).  In order to follow metastasis from a tissue, the original tissue must be labeled.  
Unfortunately, an ejaculatory bulb specific Gal4 driver does not exist, and in the absence 
of a bulb specific driver, we cannot specifically target gene expression, or a GFP 
reporter, to the EjB.  
 In order to address this problem, explant culture methods have been developed.  
I am able to isolate EjBs expressing a UAS-GFP reporter driven by the non-specific 
hsGal4 driver.  EjBs can be dissected out of the host and cultured in Schneider’s fly cell 
culture medium.  I am able to keep explanted bulbs alive for up to 5 days at 30
o
C, as 
assayed by bulb pumping and expression of GFP.  The benefit of the explant culture is 
that cells can be disrupted and introduced into a host that does not express the reporter.  
Transplanted cells can then be monitored in the host for formation of tumors. 
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Alternatively, I was able to develop a method to transplant full intact EjBs from a fly 
expressing UAS-GFP driven by hsGal4 to a host without the GFP marker.  A small 
incision was made on the side of the abdomen of the host fly.  The transplant bulb was 
then slid carefully inside the abdomen, and allowed to grow.  I was able to keep the bulb 
alive in the host carcass for up to three days, as assayed by expression of GFP in the 
transplant bulb (Fig 3.10).  This method could be used to express Ras and a reporter 
simultaneously with scribbled or bazooka RNAi in an EjB that has been transplanted 
into a wild type host.  This would allow us to determine if expression of Ras combined 
with knockdown of the apical-basal polarity genes can lead to metastasis in adult tissue. 
 
Conclusion 
 Understanding the basic mechanisms that lead to the onset of a disease is 
important for determining how best to treat and prevent it.   Unfortunately, it is often 
difficult to study the initiation of a disease in human patients.  Illnesses such as cancer 
frequently cannot be seen or diagnosed until after the disease has already established 
itself.  Healthy patients are also not very eager to subject themselves to exploratory 
testing in search of early factors that are significant to the onset of disease.  Elements 
that impact the initiation and progression of human prostate cancer can be particularly 
problematic.  As an age dependent carcinoma, the extended amount of time that factors 
have to accumulate and influence initiation of prostate cancer can make their 
identification difficult.  Due to these issues, model systems are required to accurately 
and fully examine the onset of this disease. 
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Figure 3.10.  EjBs can be transplanted into host flies.  EjB that was removed from a 
host yw carcass 3 days after transplantation into the abdomen.  The bulb was originally 
harvested from a hsGAL4;UASRas
V12
 / UAS GFP fly.  Overgrowth and GFP expression 
localized to the nucleus can be seen. 
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 Several models for human prostate cancer have been developed.   Cell culture 
lines can be useful for examining the pathways and interactions present during the 
specific point in disease progression they represent.  They also allow for biochemical 
and genetic manipulations that can be useful in understanding the basic mechanisms of 
disease.  Whole organism model systems allow for the investigation of more complex 
interactions that occur between cells and tissues in their normal biological context.  Rat 
and mouse models of prostate cancer have been developed in which tumor formation and 
metastasis can be studied (Pollard, 1998; Roy-Burman et al., 2004). However, age 
influences prostate cancer (Bostwick et al., 2004), and these systems can be 
exceptionally time consuming (Pugh et al, 1994).  The establishment of a short-lived 
prostate cancer model that allows for genetic manipulation while still maintaining 
biological context of cells would greatly improve the study of factors influencing the 
initiation of the disease.  In this chapter, I have described a Drosophila model for 
prostate cancer. 
The Drosophila ejaculatory bulb is similar in anatomy and function to the human 
prostate.  Three prostate cancer markers, acph-1, bagpipe, and shaven, and two prostate 
cancer markers, sprouty and AMACR, are simultaneously expressed exclusively in the 
ejaculatory bulb of the fly.  The normal EjB also expresses signaling pathway 
components and heparan sulfate proteoglycans known to be present in the normal 
prostate as well as in prostate cancer.  The fly bulb is able to mimic neoplasia through 
two different methods: induction of a constitutively active form of the oncogene Ras 
(RasV12) causes an increase in the epithelial thickness, and in a separate line in which the 
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EjB experiences overgrowth spontaneously.  Through incorporation and staining for the 
S-phase marker BrdU, I was able to show that overgrowth is caused by overproliferation 
of cells in the epithelial layer during Ras induction in the bulb.   
 
Gene expression patterns in Ras induced and spontaneous overgrowth bulbs 
To further examine the engineered and spontaneous Drosophila models of 
prostate cancer, and to study changes in the systems during aging, I used quantitative 
Real Time PCR to create gene expression profiles for the ejaculatory bulbs.  I looked at 
expression of four signaling pathways ligands, wg, dpp, hh, and bnl, as well as readouts 
of signaling in their pathways.  In the Ras
V12
 overgrowth EjBs, expression of wg and its 
response gene slp both increased compared to uninduced control bulbs.  The only other 
gene upregulated in Ras induced bulbs is pnt.  pnt is a response gene for the Bnl 
pathway, which works through the Ras-MAPK cascade.  Overgrowth is achieved 
through overexpression of the oncogene Ras, so pnt upregulation is expected.  In the 
spontaneous overgrowth model, upregulation of slp in overgrown bulbs is seen, similar 
to the engineered model.  However, expression of the signaling ligand for that pathway, 
wg, is decreased.  Similarly, expression of ptc and salm are increased, while hh and dpp 
expression is decreased.  It is possible that some other factor increases slp, ptc, and salm 
in these EjBs, or that changes in heparan sulfate proteoglycan expression or structure 
allow for greater sensitivity of EjB cells to the ligands.  Although expression levels of 
slp and ptc did not increase in the spontaneous model over time, they do show an 
increase when compared to aged yw control EjBs.  This suggests that normal expression 
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of these genes declines with age, but expression in overgrown bulbs remains constant 
over time.  The net result is a higher expression of the genes in overgrown bulbs than in 
normal controls, which may contribute to overgrowth. 
HSPGs can modulate Wg, Dpp, and Hh signaling (Lindner et al., 2007), and 
differences in expression or modifications to these glycoproteins may allow cells to 
better respond to signals even with less ligand available.  Previous work in our lab 
showed expression of HSPGs decreases with age in the normal EjB (Hernandez, 
unpublished data).  My examination of HSPG expression levels showed Ras induced 
overgrowth bulbs upregulated one HSPG, trol, whose mammalian homolog Perlecan is 
known to be upregulated in advanced human prostate cancers (Datta et al., 2006).  dally 
and sdc were both upregulated over time in the spontaneous overgrowth bulbs.  This 
upregulation of HSPG expression may account for the increased signaling activity 
despite lower ligand expression in the spontaneous model.  Furthermore, the large 
increase in sdc at all timepoints suggests it may be important in the spontaneous model 
overgrowth.  Interestingly, Syndecan-2 was recently shown to be upregulated in 
advanced prostate cancers (Popovic et al., 2010), and Syndecan-1 is required for 
mammary tumor formation induced by Wnt (Alexander et al., 2000).  This Syndecan-
Wnt interaction in cancer cells may explain the increase in Wg signaling seen in the 
spontaneous overgrowth bulbs.  This indicates that the spontaneous overgrowth model 
may imitate gene expression changes seen in human prostate cancer.  Although genetic 
analysis suggests the overgrowth phenotype is multigenic, the spontaneous overgrowth 
line was originally derived from an EP(Sdc)/CyO fly stock, which may impact 
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expression levels of sdc.  However, sdc expression is upregulated at all timepoints in the 
spontaneous model while overgrowth frequency increases with age, indicating that any 
impact genetic background has on sdc levels is not solely responsible for overgrowth. 
 The expression level of prostate and prostate cancer markers was assayed by 
qPCR.  In spontaneous overgrowth bulbs, a large increase was seen in the prostate 
cancer marker AMACR, as well as a general increase in sprouty, whose upregulation in 
the Ras induced model was most likely due to Ras-MAPK pathway activation.  I also 
assayed expression levels of the fly homolog of the ERG transcription factor, ETS65A, 
which is highly expressed in prostate cancer.  ERG is upregulated in response to Ras-
MAPK signaling, although its expression becomes independent of Ras in prostate cancer 
after a chromosomal rearrangement.  The level of ETS65A increases dramatically over 
time in the spontaneous overgrowth model.  Interestingly, this upregulation is 
independent of Bnl signaling.  Both bnl and pnt are downregulated at all time points in 
the spontaneous overgrowth EjBs, suggesting the increase in ETS65A expression is 
independent of Ras signaling in this model, similar to prostate cancer.  The ETS65A and 
AMACR/sprouty expression data is very exciting.  Expression patterns in the 
spontaneous model closely resemble those in human prostate cancer.  Upregulation and 
Ras-independence of ERG is important in human prostate cancer (Carver et al., 2009).  
The spontaneous model appears to upregulate the fly homolog of ERG in a Ras-
independent manner.  This suggests the spontaneous overgrowth of EjBs may be 
triggered by the same mechanisms as prostate cancer, which would make it an 
invaluable model for the initiation of the disease.  The possibility remains that ETS54A is 
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being overexpressed in response to another growth factor signaling through the Ras-
MAPK pathway, such as VEGF.   
Overexpression of the ETS transcription factors have been implicated in the 
formation of prostate tumors.  I was able to induce overgrowth in EjBs by 
overexpressing two different isoforms of the ETS factor Pnt, showing that overgrowth 
can be achieved in the fly bulb independent of the oncogene Ras. 
 Aging flies for several weeks, followed by induction and overexpression of 
Ras
v12
 for 3 or 7 days, results in unequal epithelial layer overgrowth between the two 
sides of the bulb.  This uneven growth is not seen in Ras induced overgrowth samples 
that were not aged before induction.  This asymmetric overgrowth is not unique.  As 
many as 70% of all human prostate cancers arise from one specific zone of the prostate, 
the peripheral zone (Abel, 2001).  It is possible that increased age of the flies results in 
changes that make Ras induced overgrowth more closely resemble tumor formation in 
human prostate cancer.  I examined the expression of several genes in flies aged prior to 
induction to determine if increased age results in changes in expression levels, which 
could account for the asymmetric overgrowth.  Of the genes assayed, most have the 
same general pattern whether they were not aged, aged 7, 14, 21, or 28 days prior to 
induction.  wg expression and its signaling activity remained upregulated in aged 
samples compared to uninduced EjBs, although it was decreased when compared to un-
aged induced bulbs.  sdc expression decreased in flies that were aged before Ras 
induction, which is similar to expression changes seen in the normal EjB.  This suggests 
that sdc does not participate in the overgrowth of Ras
V12
 induced bulbs at any age.  This 
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is in stark contrast to the significant upregulation of sdc seen in the spontaneous 
overgrowth model with increasing age.  The expression of the prostate cancer marker 
AMACR, already low in un-aged Ras induced overgrowth, is further decreased by aging 
samples before induction.  These data indicate that changes to the assayed gene’s 
expression levels are not likely the cause of the uneven overgrowth.  Prostate cancer is 
known to be a multigenic disease, so failing to find a single gene that causes changes in 
overgrowth is not surprising.  Further examination is needed to identify the age related 
differences that result in differential bulb overgrowth. 
 An early method for ejaculatory bulb transplantation was also described.  In the 
absence of an EjB specific Gal4 driver, it is impossible to express markers solely in the 
bulb.  Therefore, if potential metastasis from the bulb was to be studied, EjBs expressing 
a reporter must be removed from the original fly, which will have non-specific 
expression of the reporter.  The bulb and its marked cells can then be used to investigate 
potential metastasis in a host fly.  This can be achieved by disrupting the bulb and 
injecting the cells into new hosts, similar to xenograft studies in which human prostate 
cancer cells are injected into a mouse host.  The advantage to this method is that cells 
from a single bulb could be injected into hosts of different ages, which would allow the 
effects of aging on tumor formation and metastasis to be studied.  I described a method 
in which Ras
 V12
 induced overgrown EjBs marked by GFP were transplanted to the 
abdomen of wild type hosts.  These bulbs were still expressing GFP after three days, 
indicating this method can also be useful in investigating metastasis in adult tissue. 
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 The misregulation of growth factor signaling and heparan sulfate proteoglycans 
in prostate cancer has been well documented (Datta and Datta, 2006; Datta et al., 2006; 
Popovic et al., 2010).  In this chapter, I described gene expression patterns for two 
separate Drosophila prostate cancer models.  Both the engineered and spontaneous 
ejaculatory bulb overgrowth models resemble human prostate cancer in several ways, 
and each has all the benefits of a short-lived whole organism model system.  This work 
will help to create a system in which age related changes leading to the onset of prostate 
cancer can be more thoroughly and easily studied. 
 
Materials and Methods 
Drosophila stocks 
Fly stocks, including UAS-GFP LacZ.nls, UAS-Pnt P1, UAS Pnt P2, UAS-Ras
v12
, yw, the 
hsGal4 and tubGal
80
 stocks used to generate the line that drives overexpression, and the 
EP(sdc)/CyO stock the spontaneous overgrowth line was originally derived from are 
available through the Bloomington Stock Center.  dpp-LacZ and wg-LacZ were obtained 
from Dr. Ginger Carney and Dr. Keith Maggert.  Flies were grown in standard medium 
at 25°C and induced at 30°C unless otherwise stated.   
 
BrdU incorporation and staining 
Newly eclosed males were anesthetized and a 1mg/mL BrdU solution in DMSO was  
administered to the abdomen of the fly once a day for up to three days.  EjBs were then 
dissected  
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and fixed as described (Park et al., 2003). BrdU incorporation was visualized with a 
mouse primary antibody (BD Biosciences) and a peroxidase conjugated secondary 
antibody (Jackson Immunoresearch). Diaminobenzidine (DAB) was used to develop the 
secondary antibody. EjBs were mounted on slides for visualizing with a compound 
microscope. 
 
β-galactosidase activity staining 
Dissection of ejaculatory bulbs was performed at 24 days post hatching and β-
galactosidase visualization was achieved by fixing tissue with ET fix (1 X buffer B: 
formaldehyde) for 10 min at RT, washing three times with 1X PBST, and incubating in 
X-gal stain for 3 hours at 37°C. 
 
DAPI staining 
Ejaculatory bulbs were dissected and mounted immediately onto a slide containing 
Vectashield mounting medium with DAP1 (Vector Labs). DAPI staining in the bulbs 
was then visualized with a compound microscope  
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Quantitative RealTime PCR 
Whole ejaculatory bulbs were dissected and used for RNA isolation.  RNA was isolated using  
Trizol (Invitrogen) following manufacturer's directions, and further purified using the RNeasy 
kit (Invitrogen).  Samples were DNAsed and reverse transcribed using oligo dT and random  
hexamer primers.  The resulting cDNA was used to perform quantitative Real Time PCR with  
SYBR Green dye (Applied Biosystems).  All qRT-PCR reactions were carried out in triplicate at  
two different template concentrations.  Primer sequences are available upon request.  β-actin  
expression was used as an internal control.  Data were analyzed using the delta-delta calculation  
method to yield fold change compared to controls. 
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CHAPTER IV 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
My research is focused on understanding how developmental signaling pathways 
are differentially regulated in various biological contexts.  The vast number of 
developmental and biological processes that are influenced by growth factor signaling 
during the lifetime of an organism dwarfs the number of signaling pathways present that 
elicit those responses. Consequently, the same signaling components and pathways must 
be recycled many times over in order to impact so many different processes.  I am 
interested in examining how the regulation of these pathways helps to create the 
enormous diversity in function during an organism’s life.  I use Drosophila 
melanogaster as a model to study the ways in which the same growth factor signaling 
pathways can be used in different biological contexts.  Specifically, I investigate the 
ability of a heparan sulfate proteoglycan to regulate signaling in both similar and 
contrasting biological events during Drosophila development.  I also examine how the 
pathways and regulators that control development in the fly can influence the initiation 
and progression of aberrant tissue growth in a Drosophila model for prostate cancer.  By 
utilizing the vast knowledge base and biological tools available in the fruit fly, I hope to 
gain insight into the differential regulation of signaling during development and disease.  
Through my work here, I hope to not only improve our understanding of the basic 
mechanisms by which signaling impacts an organism throughout its life, but also 
127 
 
 
contribute to the field of cancer research through the description of a powerful model in 
which to study the initiation of prostate cancer. 
 
Trol Regulates Growth Factor Signaling to Activate Neuroblast 
Proliferation and Other Developmental Processes in Drosophila 
 Heparan sulfate proteoglycans are essential for proper signaling by many 
different growth factors (Hacker et al., 2005).  Numerous studies have shown that 
improper regulation of signaling pathways will lead to developmental defects or death.  
Therefore, the study of how heparan sulfate proteoglycans function in different 
developmental contexts, and how they modulate signaling by growth factors during 
these processes, is critical.  In the second chapter, I demonstrated the requirement of 
fully functional Trol during biological development in the Drosophila larval stages.  The 
ability of Trol to modulate signaling by multiple different growth factors during larval 
development was examined.  Through the use of several developmental events including 
neuroblast reactivation, plasmatocyte proliferation, and larval disc development, I was 
able to demonstrate how Trol differentially regulates growth factor pathways in both 
similar and different developmental contexts.  These studies help to expand the known 
roles of heparan sulfate proteoglycans, and Trol in particular, during development. 
 The requirement of normal Perlecan function during development has been 
demonstrated in multiple systems.  In C. elegans, mutations in the Perlecan homolog 
unc-52 lead to muscle cell defects that can cause paralysis of the worm (Rogalski et al., 
2001).  Studies in the mouse show that Perlecan is required for normal maintenance of 
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cartilage and the basement membrane, proper vascular development,  and normal 
cerebral cortex development (Costell et al., 1999; Gonzalez-Iriarte et al., 2003).  
Furthermore, Perlecan mutations can cause Silver-Handmaker syndrome, a disease with 
skeletal abnormalities due to defects in chondrogenesis (Arikawa-Hirasawa et al., 2001), 
and Schwartz-Jampel syndrome in humans, which is characterized by muscle tone 
abnormalities (Nicole et al., 2000).  Thus, a significant homology exists between 
organisms in their requirement of Perlecan/Trol for normal development,  
 In Drosophila, mutations in trol lead to decreased larval neuroblast activation 
and lethality (Datta and Kankel, 1992; Datta 1995).  It first appears defects in central 
nervous system development inhibit survival of the animals.  However, this is not the 
case.  Combining trol lethal mutants with anachronism, a mutant that enhances 
neuroblast proliferation (Ebens et al., 1993), rescues larval neuroblast proliferation, but 
not lethality (Datta, 1995).  This leads to the conclusion that trol must be essential for 
other developmental processes in the developing fly.   
 I was able to use Drosophila central nervous system development to help assess 
the role of trol in different developmental events.  Mutations in trol lead to a distinct 
neuroblast proliferation phenotype allelic series in the first instar optic lobe and central 
brain neuroblasts (Park et al, 2003).  However, lethal phase analysis showed the most 
severe mutant for first instar neuroblast reactivation progressed farther in development 
than mutants with less severe neuroblast phenotypes.  The ability of trol mutants to 
influence these two developmental events in a dissimilar fashion suggests Trol is able to 
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function differently in these processes.  One way in which Trol can have different 
impacts on developmental events is through modulation of growth factor signaling. 
 Regulation by heparan sulfate proteoglycans is required for normal signaling by 
several growth factors (Hacker et al., 2005).  Tissues and organs use different HSPGs to 
regulate these signaling pathways.  Differential regulation of signaling by proteoglycans 
may be accomplished in several ways.  Signaling molecules may have varying affinities 
for the type of modifications heparan sulfate chains exhibit.  Various sulfotransferases 
can differently modify heparan sulfate chains, leading to a high level of GAG chain 
diversity (Nakato and Kimata, 2002).  This variability gives each heparan sulfate chain 
the potential of containing numerous growth factor binding sites.  The regions of the 
heparan sulfate chains may be modified to target certain growth factors at specific times 
and locations during development (Hacker et al., 2005).  For example, Perlecan from 
different epithelial sources can have varied affinity for FGF binding (Knox et al., 2002).  
The same signaling pathway can utilize different heparan sulfate proteoglycans in 
different tissues, and multiple HSPGs can also modulate the same pathway.  For 
example, Perlecan, Glypicans, and Syndecan-3 can all modulate Hh signaling (Park et 
al., 2003; Shimo et al., 2004; Hacker et al., 2005), and Perlecan and Syndecan-4 can 
both regulate FGF2 signaling (Aviezer et al., 1997; Tkachenko et al., 2005).  The protein 
core of HSPGs can also interact with growth factors.  Along with interactions modulated 
by its heparan sulfate chains, the protein core region of Syndecan is also required for 
FGF2 signaling (Volk et al., 1999).  Therefore, the great diversity among HSPGs may 
make specific proteoglycans uniquely suited for a given tissue or developmental event.   
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To examine differences in Trol’s modulation of signaling during different 
developmental events, I analyzed proliferation in a second spatially and temporally 
distinct set of neuroblasts in the second instar Drosophila brain.  Thoracic neuroblast 
proliferation closely resembles the allelic series seen in first instar optic lobe/central 
brain neuroblasts, suggesting Trol works in a similar way during reactivation of both sets 
of cells.  Previous studies in our lab have shown that the Bnl and Hh growth factors 
interact with Trol to prompt first instar neuroblasts to exit quiescence and resume 
proliferation (Park et al., 2003).  Bnl and Hh were also shown to operate in a positive 
feedback loop to reactivate first instar optic lobe and central brain neuroblasts (Barrett et 
al., 2008).  I wanted to investigate whether these same pathways were initiating neural 
stem cell proliferation in the second instar thoracic ganglion.  I showed both the Bnl and 
Hh ligands are expressed in the thoracic ganglion, and signaling by their pathways is 
active at the appropriate time for neuroblast reactivation.  I revealed through 
overexpression and mutant analysis that both the Hedgehog and Branchless pathways 
directly influence thoracic neuroblast proliferation.  Furthermore, I showed using genetic 
interaction studies that Trol is regulating Hh and Bnl signals in the ventral ganglion.  
This data correlates with what is known about the regulation of the first instar optic lobe 
population of neural stem cells.  Therefore, the heparan sulfate proteoglycan Trol 
regulates the Hh and Bnl signaling pathways in a similar, yet distinct, developmental 
context. 
Other studies suggested that Trol would not be able to modulate Hh and Bnl 
signaling during the reactivation of quiescent neuroblasts because it was not present near 
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the cells (Voigt et al., 2002).  Previous studies from our lab have shown both Hh and Bnl 
are able to interact with Trol (Park et al., 2003).  To regulate growth factor signaling in 
this system, our model implies Trol must be near the cells that are receiving the signals.  
Voigt et al showed trol mRNA expression was present only in a few cells that were not 
near the neural stem cells.  However, they performed in situ hybridizations during third 
instar, well after the optic lobe, central brain, and thoracic neuroblasts resume 
proliferation.  Furthermore, Trol is a secreted HSPG with a long half-life, and mRNA 
expression may not accurately reflect protein localization.  Using a trol-GFP fly line, I 
was able to show that Trol protein was present near the proliferating neuroblasts at the 
appropriate times.  This is further evidence that Trol directly interacts with the two 
ligands to help reactivate quiescent cells. 
 I wanted to examine how Trol might differentially modulate signaling during 
different developmental contexts.  To accomplish this, I looked at the production of 
hemocytes during larval life.  Mature circulating hemocytes remain proliferative, 
although at a slow rate.  Activation of the Ras-MAPK pathway with Ras
V12
 increases the 
number of proliferating hemocytes (Asha et al., 2003).  The Ras-MAPK cascade can be 
activated by Vascular Endothelial Growth Factor (VEGF) and Platelet Derived Growth 
Factor (PDGF), and signaling by mammalian homologs of both growth factors has been 
linked to mammalian Perlecan (Iozzo, 2005).  Furthermore, decreasing PDGF/VEGF 
receptor function resulted in an increase in hemocyte cell death (Evans et al., 2003).  I 
wanted to test whether Trol could modulate PDGF and VEGF in this developmental 
event.  I showed that Trol-GFP is expressed on the plasmatocytes, and mutations in trol 
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decreased the number of circulating cells.  Furthermore, the mutants resulted in 
decreased VEGF/PDGF signaling.  This data shows that Trol is able to modulate the 
Ras-MAPK signaling pathway in another developmental context. 
 I wanted to examine how Trol may affect other signaling pathways.  To 
accomplish this, I looked at the Dpp, Wg, Hh, and Bnl signaling pathways in the second 
instar ventral ganglion, as well as in another developmental context, the third instar eye 
discs/brain lobes.  Gene expression analysis of dpp, wg, hh, bnl, and their pathway 
response genes in trol mutants indicates Trol is able to regulate signaling by all four 
growth factors in the second instar ventral ganglion.  However, in the third instar brain 
lobes/eye discs, Hh, Wg, and Bnl signaling efficiency was not affected by decreased 
Trol function. 
 Taken together, this data is indicates that the Drosophila Perlecan homolog Trol 
is able to differentially modulate multiple signaling pathways in different developmental 
contexts.  Trol similarly modulates signaling by all four pathways tested in the ventral 
ganglion, yet only Bnl signaling is dependent on Trol in a different developmental 
context (the third instar eye disc and brain lobe).  These data show that Trol’s regulation 
of growth factor signaling is variable based on the developmental circumstance, and is 
tissue and context specific.  My research highlights the high degree of variability that 
regulation by heparan sulfate proteoglycans can provide.  I have shown that the presence 
of both HSPGs and active signaling pathways together is not sufficient for proteoglycans 
to regulate signaling, and that HSPG modulation of growth factor pathways is a highly 
specific and regulated event. 
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Future Directions 
 The research I have presented here gives insight into the variable function 
heparan sulfates have during development.  Evidence that Trol is able to modulate 
signaling by Hh, Dpp, Wg, and Bnl in the second instar ventral ganglion, but only 
regulate Bnl signaling in the third instar brain lobes and eye discs, adds to the idea that 
pathway regulation by heparan sulfate proteoglycans is a highly specific and regulated 
process.  I believe it is necessary to further examine the specific regulation of heparan 
sulfate modification in Drosophila central nervous system development.  If the 
regulation of signaling pathways by HSPGs is as tissue and context specific as it appears 
to be, the regulation of heparan sulfate chain modification must also be tightly 
controlled.   For example, the variable binding affinity of FGF for Perlecan from 
different epithelial sources (Knox et al., 2002) demonstrates how HSPG modification 
can tissue specific.  The reactivation of two distinct populations of quiescent neuroblasts 
is regulated by very similar mechanisms in the fly brain.  Bnl and Hh signaling is 
modulated by Trol, which results in neural stem cell proliferation.  It is likely that Trol is 
specifically modified in this system, which allows the HSPG to enhance the proper 
pathways and initiate proliferation.  If the specific modification enzymes and patterns 
that allow Trol to modulate signaling in this tissue can be identified, it is possible they 
could lead to treatments that may help with neurodegenerative diseases.  
 In certain biological contexts, more than one HSPG can modulate the same 
pathway in the same tissue.  For example, Syndecan-4 and Perlecan are both able to 
regulate signaling by FGF2 (Tkachenko et al., 2005; Aviezer et al., 1997).  This suggests 
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it may be possible, under the right circumstances, to modify a proteoglycan not normally 
involved with a specific pathway in a tissue in such a way to allow it to act as a 
modulator of signaling for that pathway.  Examining how HSPGs can substitute for one 
another in certain cases may lead to insights on how to better treat human diseases 
caused by mutations to HSPGs, such as the Schwartz-Jampel and Silver-Handmaker 
syndromes. 
 
The Drosophila Ejaculatory Bulb Can Model Initiation and Progression 
of Prostate Cancer 
 The importance of developmental signaling pathways to the progression of 
cancer has been well established (Datta and Datta, 2006; Cronauer et al., 2003; 
Wakefield and Roberts, 2002; Ruiz i Altaba et al., 2004).  Misregulation of signaling 
pathways has been reported in many types of cancer.  Therefore, proper regulation of 
these growth factor pathways is as important later in life as it is during development.  In 
Chapter II, I showed that heparan sulfate proteoglycans can specifically regulate growth 
factor signaling in multiple developmental contexts.  The ability of HSPGs to modulate 
signaling remains intact later in life.  In fact, previous studies from our lab have shown 
that Perlecan can modulate growth factor signaling in prostate cancer (Datta et al., 
2006).   The signaling pathways and regulators important in cancer are the same 
pathways I showed were important to neural stem cell proliferation in Chapter II.  
However, these pathways and their modulators are not the only things cancer and stem 
cells have in common. 
135 
 
 
 The ability of a single hematopoietic stem to proliferate and reconstitute the bone 
marrow in an X-ray irradiated mouse was the first discovered by Till and McCulloch in 
1961 (reviewed, Huntly and Gilliland, 2005).  Since that time, the idea of cancer stem 
cells has been generally accepted.  Studies have shown that populations of cells in 
tumors can have stem cell characteristics.  In an integral study, cancer cells expressing 
the specific cell surface marker CD34, but not the marker CD38, were shown to have the 
ability to proliferate and reconstitute a cancer cell population in mice (Bonnet and Dick, 
1997).  These cancer cells therefore display stem cell-like qualities, which allow them to 
form tumors from a single cell.  It is possible that the same mechanisms involved in the 
reactivation of quiescent stem cells are involved in the activation and proliferation of 
stem cell-like cancer cells. 
 Prostate cancer is an age related disease, which makes examination of the onset 
and early progression difficult.  To investigate initiation of prostate carcinomas, model 
systems must be used.  The Drosophila ejaculatory bulb has the same anatomy and 
function as the human prostate.  It also expresses prostate and prostate cancer specific 
markers.  As in the activation of quiescent neuroblasts, growth factor signaling is 
important in prostate cancer.  Normal prostates exhibit growth factor signaling, which is 
then misregulated in cancers.  The fly ejaculatory bulb also expresses the signaling 
pathway components, as well as heparan sulfate proteoglycans.  Similar anatomy, 
function and markers, along with the short life span and molecular tools available, make 
the Drosophila ejaculatory bulb a good model for the human prostate.   
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 The EjB is able to mimic neoplasia by overproliferation and overgrowth in the 
epithelial layer.  Both a Ras induced and spontaneous overgrowth model have been 
isolated.  The same pathways and regulators I studied during the reactivation of neural 
stem cells have roles during prostate cancer.  I created gene expression profiles for the 
signaling ligands, pathway readouts, HSPGs, and prostate biomarkers for both the 
engineered and spontaneous fly models.  The expression of the transcription factor ERG 
(ETS65A in Drosophila), which is highly expressed in prostate carcinomas, is increased 
in the spontaneous overgrowth model, as was the prostate cancer marker AMACR.  The 
expression pattern of these genes in the spontaneous model is very exciting.  The 
similarity to the expression patterns in human prostate cancer suggests that valuable 
information can be obtained from the spontaneous model regarding initiation of the 
disease.  Several differences in expression patterns exist between the Ras engineered and 
spontaneous overgrowth, which indicates the mechanisms in which they achieve 
overgrowth are different.  This leaves us two distinct models, each of which may be 
useful.  Cancer is a highly heterogeneous disease, and model systems that have different 
hallmarks can be used to examine this heterogeneity. 
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Taken together, this data describes the Drosophila ejaculatory bulb as a model 
for prostate cancer.  My initial characterization of gene expression patterns will allow 
others to better study how the onset of this disease occurs.  The fly models will also help 
simplify analysis of the contribution age makes to prostate cancer, and my work will 
help better understand the role aging plays in gene expression changes that lead up to the 
initiation of prostate cancer.   
 
Future Directions 
 The ejaculatory bulb model for human prostate cancer is an intriguing system.  
The ability of this short-lived model to mimic neoplasia through overproliferation in the 
EjB epithelial layer may lead to many insights into prostate cancer initiation and 
progression.  I have done an initial gene expression characterization of signaling 
pathway components and heparan sulfate proteoglycans in both an oncogenic Ras 
engineered overproliferation model, as well as in a model line that displays spontaneous 
overgrowth.  I have also examined how signaling and expression of pathway regulators 
change over time in the overgrown bulbs.  It is now important to investigate the 
spontaneous overgrowth model further, in an attempt to determine the exact causes of 
overproliferation in these bulbs.  Determining the causes of spontaneous overgrowth of 
the EjB may lead to insights into the early initiation of prostate cancer. 
 I assayed expression of several genes in aged Ras induced overgrowth bulbs that 
exhibited uneven epithelial overgrowth.  However, I was not able to find significant 
changes that may have accounted for the abnormal overgrowth.  The fact that this only 
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occurs in bulbs aged before Ras induction drives overgrowth suggests that some age 
dependent component(s) are responsible for the irregular overgrowth.  Prostate cancer is 
an age related carcinoma (Bostwick et al., 2004), and most prostate cancers arise from 
one particular zone of the gland (Abel, 2001).  The asymmetric overgrowth observed 
may arise due to the aged bulb gaining features that make it more like a cancerous 
prostate.  It is therefore important to examine why older ejaculatory bulbs behave 
differently than young EjBs in response to Ras induction. 
 Another important direction to take is the induction of metastasis in the fly 
prostate cancer model.  Metastasis can be induced in larvae by combining 
overexpression of Ras with knockdown of apical-basal polarity genes (Brumby and 
Richardson, 2003; Pagliarini and Xu, 2003).  Generating an ejaculatory bulb specific 
Gal4 driver would greatly simplify many of the experiments, as you could induce genes 
specifically in the tissue you want, and monitor the fly for metastasis and secondary 
tumor growth.  Also, introducing a reporter and the apical-basal knockdown genes into 
the spontaneous overgrowth background would be interesting.  The larval metastasis 
model requires Ras induced overproliferation, and determining if the spontaneous model 
can generate metastasis without engineered overexpression of an oncogene would be 
exciting. 
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Conclusions 
 I have used the Drosophila model system to demonstrate the ability of heparan 
sulfate proteoglycans to differentially regulate multiple growth factor pathways in 
different developmental contexts.  I have shown that the fly Perlecan gene regulates 
signaling pathways in a tissue- and time-specific manner.  I have described a Drosophila 
model for prostate cancer, and examined gene expression profiles in engineered and 
spontaneous overgrowth ejaculatory bulbs.  These studies have provided insight into the 
specific regulation of growth factor signaling by heparan sulfate proteoglycans, and 
described a powerful model in which to study the initiation and progression of prostate 
cancer.  
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